Can SIBO Cause Brain Fog?
Choose where you are now
Select a guide to start reading. You can switch later.
SIBO and cognitive symptoms
The breath test and the cognitive problem are separate findings
Evidence and testing context
I think SIBO might be causing my brain fog
Can SIBO cause brain fog?
It may contribute to a distinct cognitive episode in some people. The direct evidence does not show that SIBO usually causes persistent brain fog, memory trouble or word-finding difficulty in everyone with a positive breath test.
First establish whether thinking changes in a sudden, recognisable episode after eating or remains difficult throughout the day. Those two problems need different investigations. A gas label cannot make that distinction.
Is this a meal-linked episode or an all-day problem?
A distinct meal-linked episode
Your thinking clearly changes after eating. You may feel confused, unusually slow, unable to follow a conversation, poor at judging things or “food drunk.” The episode starts and ends, and you can tell it apart from your usual self.
This is the narrower story closest to the selected 2018 study. [1]
Persistent cognitive trouble with digestive illness
Focus, memory or thinking stay poor between meals. Bloating or bowel symptoms may still matter, but poor sleep, pain, gastroparesis, restricted eating, anemia, low B12, medicines and autonomic problems become harder to ignore.
A broader gastrointestinal study did not link brain fog to SIBO or IMO test positivity. [2]
Interactive note
Which description fits what happens after you eat?
Use this before trying to name a gas subtype. It creates questions for an appointment and saves the selected descriptions to My Fog.
Choose the descriptions that match what happens
Choose every description that fits. This organises the cognitive problem before anyone tries to explain it with a gas result.
What did the famous 2018 brain-fog study actually find?
The study began with 30 selected people who already had brain fog, gas and bloating, plus eight people with clear thinking for comparison. All 30 were taking probiotics. In 20 of the 30, glucose testing brought on their usual thinking problem. SIBO and metabolic-acidosis findings were more common in that selected group. [1]
During follow-up, participants stopped probiotics and received antimicrobials. Both changes happened together, so no one can tell which caused the reported improvement. The study supports an unusual, reproducible syndrome worth investigating. It does not establish that ordinary chronic brain fog is a standard SIBO symptom.
A published response disputed the claim that probiotics caused the problem and challenged the interpretation of D-lactic acidosis. The original investigators replied. That disagreement is another reason to keep the finding narrow. [3]
Keep the finding in proportion
“Some selected probiotic users had a reproducible cognitive episode with abnormal testing” is not the same claim as “SIBO usually sends toxins to the brain and causes chronic brain fog.”
The later result
What did the later 102-person study change?
A study of 102 people having lactulose breath tests linked brain fog to gastroparesis and IBS, but not to a positive SIBO or intestinal methanogen overgrowth result. [2]
This does not rule out a contribution from SIBO. It means breath-test positivity alone is a weak explanation for the cognitive symptom. Early fullness, nausea, vomiting and prolonged fullness therefore need their own assessment.
Delayed movement
Could delayed stomach emptying be the bigger problem?
When the stomach or intestines move contents slowly, bacteria have more opportunity to remain and multiply. A person can therefore have both delayed movement and an abnormal breath test.
A meta-analysis found frequent SIBO diagnoses in people with gastroparesis. Its studies used different methods and varied widely. The two conditions often occur together; the result cannot predict whether one person has either condition. [7]
Early fullness: a few bites feel like a full meal.
Food seems to sit for hours: prolonged fullness, nausea, reflux or vomiting.
Whole-gut slowing: severe constipation, diabetes, low thyroid function, opioid use, neurological disease or previous abdominal surgery.
Meal-size effect: any large meal causes trouble, even when the ingredients change.
The test measures gases after a glucose or lactulose drink. Common North American criteria use a hydrogen rise of at least 20 parts per million by 90 minutes and methane of at least 10 parts per million at any point. Preparation, transit speed, test length, sample timing and the substrate can change the result. [5]
Hydrogen, methane and hydrogen sulfide results describe fermentation, not your thinking problem. Hydrogen sulfide testing is newer, and interpretation is not standardised in every guideline or laboratory.
A 2024 clinical practice update also warned that breath testing can be unreliable when it is used broadly in people with IBS. What a result means depends on why you had the test, how it was done and whether the whole report fits your medical history. [6]
Interactive report check
Did the breath test reproduce the problem you are trying to explain?
A gas result and a cognitive episode are two separate findings. Enter the report details and say whether your usual digestive and thinking symptoms happened during testing.
This checks what the report contains and whether your usual symptoms happened during the test. It does not diagnose SIBO, explain the cognitive problem or recommend what to do next.
How to read the combination
What do the gas result and symptom result mean together?
Gas threshold met, usual cognitive episode reproduced
The test brought on fermentation and your usual episode. The connection is stronger, but the responsible metabolite and causal direction remain unsettled.
Gas threshold met, cognitive episode absent
The result may explain digestive symptoms. It is weaker evidence that the breath-test finding explains the cognitive complaint.
Cognitive episode present, gas threshold not shown
Check glucose, food reactions, migraine, blood-pressure changes, autonomic symptoms and delayed emptying. The episode still happened even though the entered gas values did not explain it.
Neither reproduced
The test has not recreated the problem the reader is trying to understand. Use this result only for what the test measured.
Specific cognitive questions
Can SIBO cause memory or word-finding problems?
The available direct studies do not isolate memory, word finding and processing speed well enough to assign each problem to SIBO. A clear episode of confusion or poor concentration after eating is closer to the studied complaint. Persistent memory loss, language trouble or progressive decline needs a wider explanation.
Other explanations after meals
What else can look like SIBO after eating?
Glucose or medication-related change
If the episode includes shakiness, sweating, weakness or unusual hunger, check glucose instead of relying on bloating alone. Diabetes medicine also makes the timing of the episode important.
Read the blood-sugar cause →Food reaction, migraine or histamine-related symptoms
Flushing, itching, wheeze or nasal symptoms can point to a food reaction; headache may fit migraine. A racing heart needs separate assessment. Brain fog alone cannot diagnose histamine intolerance.
Read the histamine cause →Gastroparesis or slow transit
Early or long-lasting fullness, nausea, vomiting and severe constipation suggest problems with gut movement or structure, even with an abnormal breath test.
Autonomic or blood-pressure change
If lightheadedness, a racing heart or weakness worsen on standing and improve when lying down, ask about POTS and post-meal blood-pressure changes.
Read the POTS cause →Celiac disease or another malabsorption problem
Weight loss, anemia, persistent diarrhea, family history or symptoms linked to gluten need proper testing before you drop gluten.
Read the celiac cause →Ordinary post-meal sleepiness or poor sleep
A large meal can increase sleepiness. All-day unrefreshing sleep, snoring or morning headaches may explain more than the meal itself.
Read the sleep-apnea cause →For seven days, write down your normal meals, gut symptoms and thinking changes, without eating a trigger food on purpose.
Bring the full breath-test report, with the result for every breath sample. The lab summary alone isn't enough.
Bring the preparation instructions and say whether antibiotics, probiotics, laxatives, bowel preparation, smoking, vaping or exercise came before the test.
List surgery, altered bowel anatomy, diabetes, thyroid disease, constipation, neurological illness and medicines that slow gut movement.
Describe whether the cognitive problem is a distinct episode or remains between meals. That distinction changes what the test can explain.
Opening statement
My digestive symptoms and thinking problems sometimes occur together, but I want to separate the cognitive episode from the breath-test result. Please help me assess whether the report is reliable, whether delayed emptying or another movement problem could have contributed to the overgrowth, and what else could explain the cognitive symptoms.
I have SIBO and I'm treating it
What helps with SIBO?
Treatment depends on whether overgrowth, constipation, food intolerance or another problem is causing your symptoms. Choose where you need help.
What do you need help with?
Start with food triggers, bowel emptying and treatment that fits your diagnosis.
Three places to startTry a short food changeA low-FODMAP trial may ease bloating while you work out the cause.Evidence for IBS symptomsFood
Start here
FODMAPs are carbohydrates that can trigger gas and bowel symptoms. Try a limited set of food swaps, with enough food to meet your needs. Plan reintroduction from the start instead of collecting permanent food bans.
What to look for: Less bloating, pain or bowel urgency while still eating enough.
Keep in mind: Studies haven't shown it clears SIBO. If you're losing weight or already eat very few foods, keep all your current foods.
- Timing
- Guidance limits the restrictive phase to 4 to 6 weeks.
Treat difficult bowel movementsConstipation can keep bloating going after other treatment has finished.Guideline-supportedSymptom treatment
What this involves
Explain whether stools are hard, bowel movements are infrequent or soft stool is difficult to pass. A pharmacist or prescriber can help choose a stool-softening or other constipation treatment that fits.
What to look for: Softer, easier bowel movements and less fullness.
Keep in mind: Severe swelling with vomiting and inability to pass stool or gas needs urgent assessment.
Rifaximin for confirmed overgrowthAn antibiotic may reduce digestive symptoms when SIBO is the right diagnosis.Guideline-supported; limited trialsPrescription
What this involves
Before starting the prescribed course, agree which symptom it is meant to improve, such as diarrhea or bloating. Follow the prescription and arrange a review if it does not help.
What to look for: Less bloating or diarrhea and easier eating.
Keep in mind: Severe or worsening diarrhea needs prompt review. Trouble breathing or swelling of the face or throat needs emergency care.
- Cost or effort
- Prescription cost and coverage vary; check the full course before paying.
All SIBO options and evidenceTreatment, food changes and tests31 options
31 options available
Rifaximin for confirmed overgrowthAn antibiotic may reduce digestive symptoms when SIBO is the right diagnosis.Guideline-supported; limited trialsPrescription
What this involves
Before starting the prescribed course, agree which symptom it is meant to improve, such as diarrhea or bloating. Follow the prescription and arrange a review if it does not help.
What to look for: Less bloating or diarrhea and easier eating.
Keep in mind: Severe or worsening diarrhea needs prompt review. Trouble breathing or swelling of the face or throat needs emergency care.
- Cost or effort
- Prescription cost and coverage vary; check the full course before paying.
Read the evidence 4 sources
Adults; match the option to the diagnosed problem.
Digestive symptom relief, test normalization and lasting recovery are different outcomes. The much larger IBS-D trials don't count as confirmed-SIBO trials.
ACG Clinical Guideline: Small Intestinal Bacterial OvergrowthClinical guideline · Guideline, not a patient trial
- Who took part
- Adults with suspected or symptomatic SIBO; methane testing considered with constipation
- How long
- Published 2020
Compared with: Not a treatment comparison.
What the source found: Supports selected breath testing and antibiotics for symptomatic SIBO; recommendations have low or very low certainty. Methane-producing organisms are archaea and can occur beyond the small bowel.
Digestive symptoms: Not assessed as a treatment outcome.
Breath test or culture: Not assessed as a treatment outcome.
Recurrence: Not established.
Thinking and memory: No objective cognitive treatment outcome.
Important limit: Nonspecific symptoms and an imperfect test limit diagnostic certainty. This guideline does not establish one regimen for everyone.
Read Pimentel et al. (2020): ACG Clinical Guideline: Small Intestinal Bacterial OvergrowthEfficacy of rifaximin in treating with small intestine bacterial overgrowth: a systematic review and meta-analysisSystematic review and meta-analysis · 26 studies; 874 participants; 5 randomized trials included
- Who took part
- Mixed SIBO populations tested using differing methods
- How long
- Treatment and follow-up varied
Compared with: Mostly before-and-after cohorts; randomized studies used placebo or other treatments.
What the source found: About 59% had test-defined clearance in the pooled intention-to-treat analysis. The five randomized trials, totaling 203 people, did not show a clear pooled advantage over their mixed comparison treatments.
Digestive symptoms: Not assessed as a treatment outcome.
Breath test or culture: Pooled test-defined clearance 59% (95% CI 50% to 69%).
Recurrence: Not established.
Thinking and memory: No objective cognitive treatment outcome.
Important limit: Most studies were observational. A pooled clearance percentage is not a personal chance of lasting recovery.
Read Wang et al. (2021): Efficacy of rifaximin in treating with small intestine bacterial overgrowth: a systematic review and meta-analysisSymptomatic Response to Antibiotics in Patients With Small Intestinal Bacterial Overgrowth: A Systematic Review and Meta-analysisSystematic review and meta-analysis · 6 controlled studies; 196 participants
- Who took part
- Mixed populations with SIBO, including irritable bowel syndrome (IBS) and other bowel conditions
- How long
- Symptom assessment up to 30 days after treatment
Compared with: Antibiotics versus placebo or no antibiotics.
What the source found: Symptom response was more frequent with antibiotics than placebo or no antibiotic: pooled relative risk 2.46 (95% CI 1.33 to 4.55).
Digestive symptoms: Pooled response proportions were about 49.5% versus 13.7%; these are not durable cure rates.
Breath test or culture: Not assessed as a treatment outcome.
Recurrence: Not established.
Thinking and memory: No objective cognitive treatment outcome.
Important limit: Few studies, different diagnoses and response definitions, and short follow-up reduce confidence.
Read Takakura et al. (2024): Symptomatic Response to Antibiotics in Patients With Small Intestinal Bacterial Overgrowth: A Systematic Review and Meta-analysisXifaxan: US prescribing informationMedicine label · Regulatory label, not a SIBO trial
- Who took part
- People prescribed rifaximin
- How long
- Inspected September 2026; displayed label revised 2023
Compared with: Not a treatment comparison.
What the source found: US listed indications are IBS with diarrhea, specified travelers’ diarrhea and prevention of recurrent overt hepatic encephalopathy. SIBO is not a listed indication. The label warns about allergy and C. difficile-associated diarrhea.
Digestive symptoms: Not assessed as a treatment outcome.
Breath test or culture: Not assessed as a treatment outcome.
Recurrence: Not established.
Thinking and memory: No objective cognitive treatment outcome.
Important limit: This label does not define SIBO dosing. Local approvals and available formulations can differ.
Read Medicine label (2023): Xifaxan: US prescribing informationMethane and constipationA methane result can change the antibiotic discussion when constipation is a major problem.Small controlled trialPrescription
What this involves
Bring the methane result and explain how often stools are hard or difficult to pass. Rifaximin plus neomycin is one studied option, with limited evidence.
What to look for: Less straining, bloating and constipation.
Keep in mind: Neomycin can damage hearing and kidneys. The prescriber needs to review kidney function, hearing problems, pregnancy and other medicines before use.
Read the evidence 3 sources
Adults; match the option to the diagnosed problem.
The trial used an older methane threshold and had 31 participants. It does not make combination antibiotics compulsory for every positive methane test.
ACG Clinical Guideline: Small Intestinal Bacterial OvergrowthClinical guideline · Guideline, not a patient trial
- Who took part
- Adults with suspected or symptomatic SIBO; methane testing considered with constipation
- How long
- Published 2020
Compared with: Not a treatment comparison.
What the source found: Supports selected breath testing and antibiotics for symptomatic SIBO; recommendations have low or very low certainty. Methane-producing organisms are archaea and can occur beyond the small bowel.
Digestive symptoms: Not assessed as a treatment outcome.
Breath test or culture: Not assessed as a treatment outcome.
Recurrence: Not established.
Thinking and memory: No objective cognitive treatment outcome.
Important limit: Nonspecific symptoms and an imperfect test limit diagnostic certainty. This guideline does not establish one regimen for everyone.
Read Pimentel et al. (2020): ACG Clinical Guideline: Small Intestinal Bacterial OvergrowthAntibiotic treatment of constipation-predominant irritable bowel syndromeRandomized controlled trial · 31 adults
- Who took part
- Adults with constipation-predominant irritable bowel syndrome (IBS) and methane greater than 3 ppm, an older threshold
- How long
- 14 days of treatment; 4 weeks of follow-up
Compared with: Rifaximin plus neomycin versus neomycin plus placebo.
What the source found: Rifaximin plus neomycin improved constipation, straining and bloating more than neomycin alone. Pain did not improve more.
Digestive symptoms: Constipation, straining and bloating favored combination; abdominal pain did not.
Breath test or culture: People whose methane fell after treatment had less constipation.
Recurrence: Not established.
Thinking and memory: No objective cognitive treatment outcome.
Important limit: Small trial, older methane cutoff, and no rifaximin-alone arm.
Read Pimentel et al. (2014): Antibiotic treatment of constipation-predominant irritable bowel syndromeNeomycin sulfate: boxed warning and prescribing informationMedicine label · Regulatory label, not a SIBO trial
- Who took part
- People prescribed oral neomycin
- How long
- Displayed label revised October 2022
Compared with: Not a treatment comparison.
What the source found: Oral neomycin can cause kidney damage and permanent hearing loss. Kidney function, hearing/balance risk, other medicines and pregnancy require review; toxicity can appear after treatment.
Digestive symptoms: Not assessed as a treatment outcome.
Breath test or culture: Not assessed as a treatment outcome.
Recurrence: Not established.
Thinking and memory: No objective cognitive treatment outcome.
Important limit: Your body absorbs little neomycin, but these risks remain. You can't take it if you have inflammatory or ulcerative bowel disease or a bowel blockage.
Read Medicine label (2022): Neomycin sulfate: boxed warning and prescribing informationTry a short food changeA low-FODMAP trial may ease bloating while you work out the cause.Evidence for IBS symptomsFood
Start here
FODMAPs are carbohydrates that can trigger gas and bowel symptoms. Try a limited set of food swaps, with enough food to meet your needs. Plan reintroduction from the start instead of collecting permanent food bans.
What to look for: Less bloating, pain or bowel urgency while still eating enough.
Keep in mind: Studies haven't shown it clears SIBO. If you're losing weight or already eat very few foods, keep all your current foods.
- Timing
- Guidance limits the restrictive phase to 4 to 6 weeks.
Read the evidence 1 source
Adults; match the option to the diagnosed problem.
AGA Clinical Practice Update on the Role of Diet in Irritable Bowel Syndrome: Expert ReviewClinical guidance · Expert review
- Who took part
- People with irritable bowel syndrome (IBS); not a SIBO-eradication study
- How long
- Low-FODMAP restriction no more than 4 to 6 weeks before reintroduction
Compared with: Not a treatment comparison.
What the source found: Supports a limited low-FODMAP trial followed by reintroduction and a personalized diet. Soluble fiber has evidence for IBS symptoms.
Digestive symptoms: IBS symptom management, not bacterial clearance.
Breath test or culture: SIBO clearance not demonstrated.
Recurrence: Not established.
Thinking and memory: No objective cognitive treatment outcome.
Important limit: More restriction is a poor fit for people with malnutrition risk or disordered eating. There is no established SIBO clearance effect.
Read Clinical guidance (2022): AGA Clinical Practice Update on the Role of Diet in Irritable Bowel Syndrome: Expert ReviewTreat difficult bowel movementsConstipation can keep bloating going after other treatment has finished.Guideline-supportedSymptom treatment
What this involves
Explain whether stools are hard, bowel movements are infrequent or soft stool is difficult to pass. A pharmacist or prescriber can help choose a stool-softening or other constipation treatment that fits.
What to look for: Softer, easier bowel movements and less fullness.
Keep in mind: Severe swelling with vomiting and inability to pass stool or gas needs urgent assessment.
Read the evidence 2 sources
Adults; match the option to the diagnosed problem.
AGA Clinical Practice Update on Evaluation and Management of Belching, Abdominal Bloating, and DistentionClinical guidance · Expert review
- Who took part
- People with bloating, belching, constipation or visible distention
- How long
- Published 2023
Compared with: Not a treatment comparison.
What the source found: Treatment can address carbohydrate intolerance, constipation, pelvic-floor dysfunction or gut-brain symptoms. Probiotics are not recommended as a general bloating treatment.
Digestive symptoms: Supports targeted symptom management rather than one treatment for all bloating.
Breath test or culture: Not assessed as a treatment outcome.
Recurrence: Not established.
Thinking and memory: No objective cognitive treatment outcome.
Important limit: These are symptom-specific approaches. They do not establish eradication of SIBO.
Read Moshiree et al. (2023): AGA Clinical Practice Update on Evaluation and Management of Belching, Abdominal Bloating, and DistentionWorld Gastroenterology Organisation: Common GI symptomsClinical guidance · Guideline, not a SIBO trial
- Who took part
- People with common digestive symptoms
- How long
- Guideline text inspected September 2026
Compared with: Not a treatment comparison.
What the source found: Covers symptom evaluation, alarm features and simple food/eating adjustments. Describes uncertain benefit from simethicone and activated charcoal for gas.
Digestive symptoms: Not assessed as a treatment outcome.
Breath test or culture: Not assessed as a treatment outcome.
Recurrence: Not established.
Thinking and memory: No objective cognitive treatment outcome.
Important limit: Older general symptom guidance. Where probiotic advice differs, this package gives the newer AGA bloating guidance priority.
Read Clinical guidance: World Gastroenterology Organisation: Common GI symptomsWhen stool will not come outPelvic-floor treatment may help if emptying is difficult even when stool is soft.For a confirmed muscle-coordination problemSymptom treatment
What this involves
An assessment can check whether the muscles used for bowel movements tighten when they need to relax. Biofeedback teaches you to coordinate those muscles while practising the movement.
What to look for: Less straining and a more complete bowel movement.
Keep in mind: The treatment is useful when testing confirms difficulty coordinating these muscles.
Read the evidence 1 source
Adults; match the option to the diagnosed problem.
AGA Clinical Practice Update on Evaluation and Management of Belching, Abdominal Bloating, and DistentionClinical guidance · Expert review
- Who took part
- People with bloating, belching, constipation or visible distention
- How long
- Published 2023
Compared with: Not a treatment comparison.
What the source found: Treatment can address carbohydrate intolerance, constipation, pelvic-floor dysfunction or gut-brain symptoms. Probiotics are not recommended as a general bloating treatment.
Digestive symptoms: Supports targeted symptom management rather than one treatment for all bloating.
Breath test or culture: Not assessed as a treatment outcome.
Recurrence: Not established.
Thinking and memory: No objective cognitive treatment outcome.
Important limit: These are symptom-specific approaches. They do not establish eradication of SIBO.
Read Moshiree et al. (2023): AGA Clinical Practice Update on Evaluation and Management of Belching, Abdominal Bloating, and DistentionWork out why symptoms returnedReview the original response and anything that may slow digestion.Guideline-supportedAssessment
What this involves
Bring the original test and treatment details. Say what improved, how long it lasted, and whether constipation, previous bowel surgery or a diagnosed motility problem is still present.
What to look for: A next treatment aimed at the remaining problem.
Keep in mind: A return of bloating alone cannot tell you whether overgrowth returned.
Read the evidence 3 sources
Adults; match the option to the diagnosed problem.
AGA Clinical Practice Update on Small Intestinal Bacterial Overgrowth: Expert ReviewExpert guidance · Expert review, not a patient trial
- Who took part
- People evaluated or treated for SIBO
- How long
- Published 2020
Compared with: Not a treatment comparison.
What the source found: Treatment means dealing with an underlying cause, correcting nutritional deficiencies and, where appropriate, taking antibiotics. Severe malabsorption needs extra attention.
Digestive symptoms: Symptom and nutritional response guide care; no pooled treatment estimate.
Breath test or culture: Not assessed as a treatment outcome.
Recurrence: Not established.
Thinking and memory: No objective cognitive treatment outcome.
Important limit: The best antibiotic approach and SIBO's role in common functional bowel symptoms are still unclear.
Read Quigley et al. (2020): AGA Clinical Practice Update on Small Intestinal Bacterial Overgrowth: Expert ReviewCritical appraisal of the SIBO hypothesis and breath testing: ESNM/ANMS clinical practice updateSociety-endorsed critical review · Critical review, not a patient trial
- Who took part
- Especially irritable bowel syndrome (IBS) and other disorders of gut-brain interaction
- How long
- Published 2024
Compared with: Not a treatment comparison.
What the source found: It questions routinely diagnosing SIBO by breath test in people with IBS, especially when fast-moving food skews lactulose results. It recognizes classic overgrowth when gut anatomy or movement is impaired.
Digestive symptoms: Not assessed as a treatment outcome.
Breath test or culture: Not assessed as a treatment outcome.
Recurrence: Not established.
Thinking and memory: No objective cognitive treatment outcome.
Important limit: Its recommendations differ from ACG guidance. These disagreements should remain visible when a result is borderline or treatment repeatedly fails.
Read Kashyap et al. (2024): Critical appraisal of the SIBO hypothesis and breath testing: ESNM/ANMS clinical practice updateSmall intestinal bacterial overgrowth recurrence after antibiotic therapyProspective follow-up cohort · 80 initial responders
- Who took part
- People whose glucose breath test normalized after rifaximin
- How long
- 3, 6 and 9 months
Compared with: No randomized prevention comparison.
What the source found: Positive tests returned in 12.6%, 27.5% and 43.7% at the three follow-up points.
Digestive symptoms: Not assessed as a treatment outcome.
Breath test or culture: Repeat glucose breath testing.
Recurrence: 43.7% had a positive test at 9 months.
Thinking and memory: No objective cognitive treatment outcome.
Important limit: Researchers followed only the people whose treatment worked at first.
Read Lauritano et al. (2008): Small intestinal bacterial overgrowth recurrence after antibiotic therapyRifaximin did not helpBefore another course, check the diagnosis and the symptom you are trying to change.Guideline-supportedAssessment
What this involves
Compare the original test, why you had it and what happened during treatment. Persistent diarrhea, constipation, pain or brain fog may need different investigations.
What to look for: A clearer explanation and fewer ineffective repeat courses.
Keep in mind: Lack of improvement does not identify the next antibiotic or prove antibiotic resistance.
Review what changed after treatment
Read the evidence 2 sources
Adults; match the option to the diagnosed problem.
AGA Clinical Practice Update on Small Intestinal Bacterial Overgrowth: Expert ReviewExpert guidance · Expert review, not a patient trial
- Who took part
- People evaluated or treated for SIBO
- How long
- Published 2020
Compared with: Not a treatment comparison.
What the source found: Treatment means dealing with an underlying cause, correcting nutritional deficiencies and, where appropriate, taking antibiotics. Severe malabsorption needs extra attention.
Digestive symptoms: Symptom and nutritional response guide care; no pooled treatment estimate.
Breath test or culture: Not assessed as a treatment outcome.
Recurrence: Not established.
Thinking and memory: No objective cognitive treatment outcome.
Important limit: The best antibiotic approach and SIBO's role in common functional bowel symptoms are still unclear.
Read Quigley et al. (2020): AGA Clinical Practice Update on Small Intestinal Bacterial Overgrowth: Expert ReviewCritical appraisal of the SIBO hypothesis and breath testing: ESNM/ANMS clinical practice updateSociety-endorsed critical review · Critical review, not a patient trial
- Who took part
- Especially irritable bowel syndrome (IBS) and other disorders of gut-brain interaction
- How long
- Published 2024
Compared with: Not a treatment comparison.
What the source found: It questions routinely diagnosing SIBO by breath test in people with IBS, especially when fast-moving food skews lactulose results. It recognizes classic overgrowth when gut anatomy or movement is impaired.
Digestive symptoms: Not assessed as a treatment outcome.
Breath test or culture: Not assessed as a treatment outcome.
Recurrence: Not established.
Thinking and memory: No objective cognitive treatment outcome.
Important limit: Its recommendations differ from ACG guidance. These disagreements should remain visible when a result is borderline or treatment repeatedly fails.
Read Kashyap et al. (2024): Critical appraisal of the SIBO hypothesis and breath testing: ESNM/ANMS clinical practice updateCheck what your breath test showsThe test preparation and gas readings matter as much as a positive label.Imperfect test; guidance differsAssessment
What this involves
Keep the full report, including the test drink, baseline gases and timed samples. Open the report checker to prepare questions about the result.
What to look for: Understanding whether the result fits your symptoms and risk factors.
Keep in mind: Fast transit and preparation problems can distort results, especially with lactulose.
Open the breath-test report check
Read the evidence 4 sources
Adults; match the option to the diagnosed problem.
ACG Clinical Guideline: Small Intestinal Bacterial OvergrowthClinical guideline · Guideline, not a patient trial
- Who took part
- Adults with suspected or symptomatic SIBO; methane testing considered with constipation
- How long
- Published 2020
Compared with: Not a treatment comparison.
What the source found: Supports selected breath testing and antibiotics for symptomatic SIBO; recommendations have low or very low certainty. Methane-producing organisms are archaea and can occur beyond the small bowel.
Digestive symptoms: Not assessed as a treatment outcome.
Breath test or culture: Not assessed as a treatment outcome.
Recurrence: Not established.
Thinking and memory: No objective cognitive treatment outcome.
Important limit: Nonspecific symptoms and an imperfect test limit diagnostic certainty. This guideline does not establish one regimen for everyone.
Read Pimentel et al. (2020): ACG Clinical Guideline: Small Intestinal Bacterial OvergrowthCritical appraisal of the SIBO hypothesis and breath testing: ESNM/ANMS clinical practice updateSociety-endorsed critical review · Critical review, not a patient trial
- Who took part
- Especially irritable bowel syndrome (IBS) and other disorders of gut-brain interaction
- How long
- Published 2024
Compared with: Not a treatment comparison.
What the source found: It questions routinely diagnosing SIBO by breath test in people with IBS, especially when fast-moving food skews lactulose results. It recognizes classic overgrowth when gut anatomy or movement is impaired.
Digestive symptoms: Not assessed as a treatment outcome.
Breath test or culture: Not assessed as a treatment outcome.
Recurrence: Not established.
Thinking and memory: No objective cognitive treatment outcome.
Important limit: Its recommendations differ from ACG guidance. These disagreements should remain visible when a result is borderline or treatment repeatedly fails.
Read Kashyap et al. (2024): Critical appraisal of the SIBO hypothesis and breath testing: ESNM/ANMS clinical practice updateHydrogen and Methane-Based Breath Testing in Gastrointestinal Disorders: The North American ConsensusTesting consensus · Consensus, not a treatment trial
- Who took part
- Patients having hydrogen or methane breath tests
- How long
- Published 2017
Compared with: Not a treatment comparison.
What the source found: It defines the usual preparation and gas cutoffs. Recent antibiotics, laxatives, gut-movement medicines, the pre-test diet and sampling can change what a result means.
Digestive symptoms: Not assessed as a treatment outcome.
Breath test or culture: Not assessed as a treatment outcome.
Recurrence: Not established.
Thinking and memory: No objective cognitive treatment outcome.
Important limit: Preparation should follow the testing service and prescriber. Thresholds are clinical conventions, not proof that the result explains every symptom.
Read Rezaie et al. (2017): Hydrogen and Methane-Based Breath Testing in Gastrointestinal Disorders: The North American ConsensusBreath Tests for the Non-invasive Diagnosis of Small Intestinal Bacterial Overgrowth: A Systematic Review With Meta-analysisDiagnostic systematic review · 14 studies
- Who took part
- People investigated for SIBO in differing clinical settings
- How long
- Diagnostic comparisons at testing
Compared with: Breath testing versus small-bowel aspirate culture.
What the source found: Pooled sensitivity/specificity were 54.5%/83.2% for glucose and 42.0%/70.6% for lactulose, compared with aspirate culture.
Digestive symptoms: Not assessed as a treatment outcome.
Breath test or culture: Glucose performed better overall, but both missed cases and produced false positives.
Recurrence: Not established.
Thinking and memory: No objective cognitive treatment outcome.
Important limit: Aspirate sampling is itself imperfect. Results vary with underlying risk and protocol; these figures are not a consumer test accuracy guarantee.
Read Losurdo et al. (2020): Breath Tests for the Non-invasive Diagnosis of Small Intestinal Bacterial Overgrowth: A Systematic Review With Meta-analysisPrepare correctly for a breath testCheck the laboratory instructions before changing food or medicines.Testing guidancePractical help
Start here
Ask the testing service about recent antibiotics, laxatives and medicines that change bowel movement. Follow its food and fasting instructions and disclose anything you could not follow.
What to look for: A result that is easier to interpret.
Keep in mind: Only stop an essential medicine if your prescriber agrees.
Read the evidence 1 source
Adults; match the option to the diagnosed problem.
Hydrogen and Methane-Based Breath Testing in Gastrointestinal Disorders: The North American ConsensusTesting consensus · Consensus, not a treatment trial
- Who took part
- Patients having hydrogen or methane breath tests
- How long
- Published 2017
Compared with: Not a treatment comparison.
What the source found: It defines the usual preparation and gas cutoffs. Recent antibiotics, laxatives, gut-movement medicines, the pre-test diet and sampling can change what a result means.
Digestive symptoms: Not assessed as a treatment outcome.
Breath test or culture: Not assessed as a treatment outcome.
Recurrence: Not established.
Thinking and memory: No objective cognitive treatment outcome.
Important limit: Preparation should follow the testing service and prescriber. Thresholds are clinical conventions, not proof that the result explains every symptom.
Read Rezaie et al. (2017): Hydrogen and Methane-Based Breath Testing in Gastrointestinal Disorders: The North American ConsensusKnow what a repeat test will changeA repeat test is useful only when the result will affect your care.Limited evidence for routine retestingAssessment
What this involves
Before paying, ask what will happen if the result is positive and what will happen if it is negative. Include whether your symptoms and eating have already improved.
What to look for: Avoiding tests that leave the treatment decision unchanged.
Keep in mind: Evidence that routine repeated testing improves long-term recovery is limited.
Read the evidence 3 sources
Adults; match the option to the diagnosed problem.
AGA Clinical Practice Update on Small Intestinal Bacterial Overgrowth: Expert ReviewExpert guidance · Expert review, not a patient trial
- Who took part
- People evaluated or treated for SIBO
- How long
- Published 2020
Compared with: Not a treatment comparison.
What the source found: Treatment means dealing with an underlying cause, correcting nutritional deficiencies and, where appropriate, taking antibiotics. Severe malabsorption needs extra attention.
Digestive symptoms: Symptom and nutritional response guide care; no pooled treatment estimate.
Breath test or culture: Not assessed as a treatment outcome.
Recurrence: Not established.
Thinking and memory: No objective cognitive treatment outcome.
Important limit: The best antibiotic approach and SIBO's role in common functional bowel symptoms are still unclear.
Read Quigley et al. (2020): AGA Clinical Practice Update on Small Intestinal Bacterial Overgrowth: Expert ReviewCritical appraisal of the SIBO hypothesis and breath testing: ESNM/ANMS clinical practice updateSociety-endorsed critical review · Critical review, not a patient trial
- Who took part
- Especially irritable bowel syndrome (IBS) and other disorders of gut-brain interaction
- How long
- Published 2024
Compared with: Not a treatment comparison.
What the source found: It questions routinely diagnosing SIBO by breath test in people with IBS, especially when fast-moving food skews lactulose results. It recognizes classic overgrowth when gut anatomy or movement is impaired.
Digestive symptoms: Not assessed as a treatment outcome.
Breath test or culture: Not assessed as a treatment outcome.
Recurrence: Not established.
Thinking and memory: No objective cognitive treatment outcome.
Important limit: Its recommendations differ from ACG guidance. These disagreements should remain visible when a result is borderline or treatment repeatedly fails.
Read Kashyap et al. (2024): Critical appraisal of the SIBO hypothesis and breath testing: ESNM/ANMS clinical practice updateSmall intestinal bacterial overgrowth recurrence after antibiotic therapyProspective follow-up cohort · 80 initial responders
- Who took part
- People whose glucose breath test normalized after rifaximin
- How long
- 3, 6 and 9 months
Compared with: No randomized prevention comparison.
What the source found: Positive tests returned in 12.6%, 27.5% and 43.7% at the three follow-up points.
Digestive symptoms: Not assessed as a treatment outcome.
Breath test or culture: Repeat glucose breath testing.
Recurrence: 43.7% had a positive test at 9 months.
Thinking and memory: No objective cognitive treatment outcome.
Important limit: Researchers followed only the people whose treatment worked at first.
Read Lauritano et al. (2008): Small intestinal bacterial overgrowth recurrence after antibiotic therapyHydrogen sulfide resultsNewer research links this breath gas to gut microbes, but treatment questions remain.Emerging evidenceEvidence check
Before considering this
When offered a three-gas test, ask which hydrogen sulfide cutoff the laboratory uses and how the result would change treatment.
What to look for: A better-informed decision about whether the extra test is useful.
Keep in mind: Evidence does not yet establish a standard treatment or low-sulfur diet for everyone with a result.
Read the evidence 2 sources
Adults; match the option to the diagnosed problem.
Critical appraisal of the SIBO hypothesis and breath testing: ESNM/ANMS clinical practice updateSociety-endorsed critical review · Critical review, not a patient trial
- Who took part
- Especially irritable bowel syndrome (IBS) and other disorders of gut-brain interaction
- How long
- Published 2024
Compared with: Not a treatment comparison.
What the source found: It questions routinely diagnosing SIBO by breath test in people with IBS, especially when fast-moving food skews lactulose results. It recognizes classic overgrowth when gut anatomy or movement is impaired.
Digestive symptoms: Not assessed as a treatment outcome.
Breath test or culture: Not assessed as a treatment outcome.
Recurrence: Not established.
Thinking and memory: No objective cognitive treatment outcome.
Important limit: Its recommendations differ from ACG guidance. These disagreements should remain visible when a result is borderline or treatment repeatedly fails.
Read Kashyap et al. (2024): Critical appraisal of the SIBO hypothesis and breath testing: ESNM/ANMS clinical practice updateHydrogen Sulfide and Methane on Breath Test Correlate with Human Small Intestinal Hydrogen Sulfide Producers and MethanogensObservational microbiome study · 110 participants; hydrogen sulfide measured in 109
- Who took part
- Adults undergoing upper endoscopy in the REIMAGINE study
- How long
- Single assessment
Compared with: Breath gases compared with small-bowel microbial composition.
What the source found: Breath methane and hydrogen sulfide correlated with relevant microbes in small-bowel samples.
Digestive symptoms: Not assessed as a treatment outcome.
Breath test or culture: Biological correlations, not proof of treatment selection.
Recurrence: Not established.
Thinking and memory: No objective cognitive treatment outcome.
Important limit: This study used a single fasting sample. Several authors reported ties to the diagnostic industry.
Read Villanueva-Millan et al. (2025): Hydrogen Sulfide and Methane on Breath Test Correlate with Human Small Intestinal Hydrogen Sulfide Producers and MethanogensBring foods backAfter a restrictive diet helps, find out which foods you can eat again.IBS dietary guidanceFood
Start here
Reintroduce one restricted food group at a time while keeping the rest of your meals familiar. Build toward the widest diet you can comfortably manage.
What to look for: More food choices without a large return of symptoms.
Keep in mind: Leave any known food allergen out when you test foods yourself. With diagnosed celiac disease, leave gluten out too.
Read the evidence 1 source
Adults; match the option to the diagnosed problem.
AGA Clinical Practice Update on the Role of Diet in Irritable Bowel Syndrome: Expert ReviewClinical guidance · Expert review
- Who took part
- People with irritable bowel syndrome (IBS); not a SIBO-eradication study
- How long
- Low-FODMAP restriction no more than 4 to 6 weeks before reintroduction
Compared with: Not a treatment comparison.
What the source found: Supports a limited low-FODMAP trial followed by reintroduction and a personalized diet. Soluble fiber has evidence for IBS symptoms.
Digestive symptoms: IBS symptom management, not bacterial clearance.
Breath test or culture: SIBO clearance not demonstrated.
Recurrence: Not established.
Thinking and memory: No objective cognitive treatment outcome.
Important limit: More restriction is a poor fit for people with malnutrition risk or disordered eating. There is no established SIBO clearance effect.
Read Clinical guidance (2022): AGA Clinical Practice Update on the Role of Diet in Irritable Bowel Syndrome: Expert ReviewMake sure you are eating enoughA shrinking food list can add weakness and fatigue to digestive symptoms.Nutritional careFood
Start here
Keep enough meals and tolerated foods available. If you are losing weight or struggling to meet basic needs, a dietitian can help replace what is missing.
What to look for: Stable weight, better energy and less fear around meals.
Keep in mind: Ongoing vomiting, marked weight loss or dehydration needs assessment rather than a stricter diet.
Read the evidence 2 sources
Adults; match the option to the diagnosed problem.
AGA Clinical Practice Update on Small Intestinal Bacterial Overgrowth: Expert ReviewExpert guidance · Expert review, not a patient trial
- Who took part
- People evaluated or treated for SIBO
- How long
- Published 2020
Compared with: Not a treatment comparison.
What the source found: Treatment means dealing with an underlying cause, correcting nutritional deficiencies and, where appropriate, taking antibiotics. Severe malabsorption needs extra attention.
Digestive symptoms: Symptom and nutritional response guide care; no pooled treatment estimate.
Breath test or culture: Not assessed as a treatment outcome.
Recurrence: Not established.
Thinking and memory: No objective cognitive treatment outcome.
Important limit: The best antibiotic approach and SIBO's role in common functional bowel symptoms are still unclear.
Read Quigley et al. (2020): AGA Clinical Practice Update on Small Intestinal Bacterial Overgrowth: Expert ReviewAGA Clinical Practice Update on the Role of Diet in Irritable Bowel Syndrome: Expert ReviewClinical guidance · Expert review
- Who took part
- People with irritable bowel syndrome (IBS); not a SIBO-eradication study
- How long
- Low-FODMAP restriction no more than 4 to 6 weeks before reintroduction
Compared with: Not a treatment comparison.
What the source found: Supports a limited low-FODMAP trial followed by reintroduction and a personalized diet. Soluble fiber has evidence for IBS symptoms.
Digestive symptoms: IBS symptom management, not bacterial clearance.
Breath test or culture: SIBO clearance not demonstrated.
Recurrence: Not established.
Thinking and memory: No objective cognitive treatment outcome.
Important limit: More restriction is a poor fit for people with malnutrition risk or disordered eating. There is no established SIBO clearance effect.
Read Clinical guidance (2022): AGA Clinical Practice Update on the Role of Diet in Irritable Bowel Syndrome: Expert ReviewCheck a specific food intoleranceMilk sugar or other poorly absorbed carbohydrates can cause symptoms separately from SIBO.Targeted symptom careFood
Start here
If dairy repeatedly triggers symptoms, try a lactose-free version to keep dairy's nutrients. A dietitian or testing service can help when the trigger is unclear.
What to look for: Fewer symptoms with a smaller, more specific food change.
Keep in mind: A response to one food change cannot confirm SIBO.
Read the evidence 2 sources
Adults; match the option to the diagnosed problem.
AGA Clinical Practice Update on the Role of Diet in Irritable Bowel Syndrome: Expert ReviewClinical guidance · Expert review
- Who took part
- People with irritable bowel syndrome (IBS); not a SIBO-eradication study
- How long
- Low-FODMAP restriction no more than 4 to 6 weeks before reintroduction
Compared with: Not a treatment comparison.
What the source found: Supports a limited low-FODMAP trial followed by reintroduction and a personalized diet. Soluble fiber has evidence for IBS symptoms.
Digestive symptoms: IBS symptom management, not bacterial clearance.
Breath test or culture: SIBO clearance not demonstrated.
Recurrence: Not established.
Thinking and memory: No objective cognitive treatment outcome.
Important limit: More restriction is a poor fit for people with malnutrition risk or disordered eating. There is no established SIBO clearance effect.
Read Clinical guidance (2022): AGA Clinical Practice Update on the Role of Diet in Irritable Bowel Syndrome: Expert ReviewAGA Clinical Practice Update on Evaluation and Management of Belching, Abdominal Bloating, and DistentionClinical guidance · Expert review
- Who took part
- People with bloating, belching, constipation or visible distention
- How long
- Published 2023
Compared with: Not a treatment comparison.
What the source found: Treatment can address carbohydrate intolerance, constipation, pelvic-floor dysfunction or gut-brain symptoms. Probiotics are not recommended as a general bloating treatment.
Digestive symptoms: Supports targeted symptom management rather than one treatment for all bloating.
Breath test or culture: Not assessed as a treatment outcome.
Recurrence: Not established.
Thinking and memory: No objective cognitive treatment outcome.
Important limit: These are symptom-specific approaches. They do not establish eradication of SIBO.
Read Moshiree et al. (2023): AGA Clinical Practice Update on Evaluation and Management of Belching, Abdominal Bloating, and DistentionUnderstand an elemental dietA nutritionally complete liquid formula replaces food for a supervised treatment period.Small uncontrolled studiesDiet treatment
What this involves
Before starting, arrange enough prescribed formula to meet your nutritional needs, a contact for problems and a plan for returning to food. Review the full cost before ordering.
What to look for: Easier digestion and improved symptoms in some people.
Keep in mind: Severe diarrhea, vomiting, weakness or worsening confusion needs prompt review. A homemade liquid diet can leave you short of essential nutrition.
- Timing
- The newer study used two weeks of formula followed by food reintroduction.
Read the evidence 2 sources
Adults; match the option to the diagnosed problem.
The 2025 study enrolled 30 adults with no comparison group.
AGA Clinical Practice Update on Small Intestinal Bacterial Overgrowth: Expert ReviewExpert guidance · Expert review, not a patient trial
- Who took part
- People evaluated or treated for SIBO
- How long
- Published 2020
Compared with: Not a treatment comparison.
What the source found: Treatment means dealing with an underlying cause, correcting nutritional deficiencies and, where appropriate, taking antibiotics. Severe malabsorption needs extra attention.
Digestive symptoms: Symptom and nutritional response guide care; no pooled treatment estimate.
Breath test or culture: Not assessed as a treatment outcome.
Recurrence: Not established.
Thinking and memory: No objective cognitive treatment outcome.
Important limit: The best antibiotic approach and SIBO's role in common functional bowel symptoms are still unclear.
Read Quigley et al. (2020): AGA Clinical Practice Update on Small Intestinal Bacterial Overgrowth: Expert ReviewEffect, Tolerability, and Safety of Exclusive Palatable Elemental Diet in Patients With Intestinal Microbial OvergrowthOpen-label prospective study · 30 adults
- Who took part
- Adults with SIBO, IMO or both
- How long
- 2-week exclusive formula diet, followed by food reintroduction
Compared with: Before versus after the diet; no concurrent control.
What the source found: 73% normalized their breath test; 83% reported adequate global symptom relief.
Digestive symptoms: 83% reported adequate global symptom relief.
Breath test or culture: 73% breath-test normalization.
Recurrence: Not established.
Thinking and memory: No objective cognitive treatment outcome.
Important limit: No control group; short follow-up and commercial interests. The primary endpoint was microbiome change, and longer-term benefit remains uncertain.
Read Rezaie et al. (2025): Effect, Tolerability, and Safety of Exclusive Palatable Elemental Diet in Patients With Intestinal Microbial OvergrowthWhen a probiotic makes you feel worseYou do not need to keep adding probiotics because a gut protocol says so.Mixed, product-specific evidenceEvidence check
Before considering this
Name the product and say whether new symptoms began after you started it. Skip adding several more products to counter the reaction. For a self-started supplement, pause it while reviewing the change.
What to look for: Whether the new discomfort settles without further additions.
Keep in mind: People with short bowel, severe immune suppression or serious illness need individual advice before using live-microbe products.
Read the evidence 5 sources
Adults; match the option to the diagnosed problem.
Positive pooled studies do not identify a universally useful strain. The famous brain-fog report cannot prove probiotics caused its participants’ symptoms.
AGA Clinical Practice Update on Evaluation and Management of Belching, Abdominal Bloating, and DistentionClinical guidance · Expert review
- Who took part
- People with bloating, belching, constipation or visible distention
- How long
- Published 2023
Compared with: Not a treatment comparison.
What the source found: Treatment can address carbohydrate intolerance, constipation, pelvic-floor dysfunction or gut-brain symptoms. Probiotics are not recommended as a general bloating treatment.
Digestive symptoms: Supports targeted symptom management rather than one treatment for all bloating.
Breath test or culture: Not assessed as a treatment outcome.
Recurrence: Not established.
Thinking and memory: No objective cognitive treatment outcome.
Important limit: These are symptom-specific approaches. They do not establish eradication of SIBO.
Read Moshiree et al. (2023): AGA Clinical Practice Update on Evaluation and Management of Belching, Abdominal Bloating, and DistentionAlternative Treatment Approaches to Small Intestinal Bacterial Overgrowth: A Systematic ReviewSystematic review · 8 included studies
- Who took part
- Small, varied SIBO treatment populations
- How long
- Protocols varied
Compared with: Not a treatment comparison.
What the source found: Probiotics, diets and herbal products have early results but lack large standardized trials.
Digestive symptoms: Not assessed as a treatment outcome.
Breath test or culture: Not assessed as a treatment outcome.
Recurrence: Not established.
Thinking and memory: No objective cognitive treatment outcome.
Important limit: Different tests, products and symptom measures make comparisons unreliable. Results do not validate a generic supplement stack.
Read Nickles et al. (2021): Alternative Treatment Approaches to Small Intestinal Bacterial Overgrowth: A Systematic ReviewProbiotics for Preventing and Treating Small Intestinal Bacterial Overgrowth: A Meta-Analysis and Systematic ReviewSystematic review and meta-analysis · 18 studies in synthesis
- Who took part
- Mixed populations, probiotic strains and protocols
- How long
- Durations varied
Compared with: Not a treatment comparison.
What the source found: Some pooled test and pain outcomes favored probiotics. Prevention was uncertain: relative risk 0.54, with a wide 95% CI of 0.19 to 1.52.
Digestive symptoms: Some pain benefit; no clear stool-frequency benefit.
Breath test or culture: Pooled test-defined clearance favored probiotics in selected comparisons.
Recurrence: Reliable prevention was not demonstrated.
Thinking and memory: No objective cognitive treatment outcome.
Important limit: The results cannot select a strain for one patient or justify taking probiotics indefinitely. Later bloating guidance recommends against routine probiotic use for that symptom.
Read Zhong et al. (2017): Probiotics for Preventing and Treating Small Intestinal Bacterial Overgrowth: A Meta-Analysis and Systematic ReviewBrain fogginess, gas and bloating: a link between SIBO, probiotics and metabolic acidosisSelected observational study · 30 with brain fog and 8 without
- Who took part
- Patients with intact bowel, gas/bloating and episodic brain fog; a small comparison group
- How long
- Testing plus follow-up after treatment changes
Compared with: Selected symptomatic group versus 8 without brain fog; uncontrolled treatment follow-up.
What the source found: In a selected group with digestive symptoms and brain fog, participants stopped probiotics, some took antibiotics, and researchers reported improvement.
Digestive symptoms: Not assessed as a treatment outcome.
Breath test or culture: Not assessed as a treatment outcome.
Recurrence: Not established.
Thinking and memory: Self-reported episodes; not a blinded objective cognitive-treatment trial.
Important limit: Two changes occurred together, without randomized treatment. The study cannot establish probiotic causation or an antibiotic cure for everyday brain fog.
Read Rao et al. (2018): Brain fogginess, gas and bloating: a link between SIBO, probiotics and metabolic acidosis'Brain Fogginess' and D-Lactic Acidosis: Probiotics Are Not the CausePublished scientific response · No new trial
- Who took part
- Critique of the 2018 selected-patient report
- How long
- Published 2018
Compared with: Not a treatment comparison.
What the source found: Challenges the proposed probiotic causation and interpretation of D-lactic acidosis.
Digestive symptoms: Not assessed as a treatment outcome.
Breath test or culture: Not assessed as a treatment outcome.
Recurrence: Not established.
Thinking and memory: No new cognitive data.
Important limit: A critique is not proof that no individual reacts to a probiotic. Both sides reported relevant commercial interests.
Read Quigley et al. (2018): 'Brain Fogginess' and D-Lactic Acidosis: Probiotics Are Not the CauseFind a fiber you can tolerateFiber choice and amount matter when constipation and bloating occur together.Evidence for IBS symptomsFood
Start here
Choose a soluble-fiber option with your bowel-treatment plan and introduce it gradually. Add one fiber powder at a time.
What to look for: Easier stools without a large increase in bloating.
Keep in mind: A sudden increase can make gas worse. Suspected bowel obstruction needs assessment before more fiber.
Read the evidence 2 sources
Adults; match the option to the diagnosed problem.
AGA Clinical Practice Update on the Role of Diet in Irritable Bowel Syndrome: Expert ReviewClinical guidance · Expert review
- Who took part
- People with irritable bowel syndrome (IBS); not a SIBO-eradication study
- How long
- Low-FODMAP restriction no more than 4 to 6 weeks before reintroduction
Compared with: Not a treatment comparison.
What the source found: Supports a limited low-FODMAP trial followed by reintroduction and a personalized diet. Soluble fiber has evidence for IBS symptoms.
Digestive symptoms: IBS symptom management, not bacterial clearance.
Breath test or culture: SIBO clearance not demonstrated.
Recurrence: Not established.
Thinking and memory: No objective cognitive treatment outcome.
Important limit: More restriction is a poor fit for people with malnutrition risk or disordered eating. There is no established SIBO clearance effect.
Read Clinical guidance (2022): AGA Clinical Practice Update on the Role of Diet in Irritable Bowel Syndrome: Expert ReviewWorld Gastroenterology Organisation: Common GI symptomsClinical guidance · Guideline, not a SIBO trial
- Who took part
- People with common digestive symptoms
- How long
- Guideline text inspected September 2026
Compared with: Not a treatment comparison.
What the source found: Covers symptom evaluation, alarm features and simple food/eating adjustments. Describes uncertain benefit from simethicone and activated charcoal for gas.
Digestive symptoms: Not assessed as a treatment outcome.
Breath test or culture: Not assessed as a treatment outcome.
Recurrence: Not established.
Thinking and memory: No objective cognitive treatment outcome.
Important limit: Older general symptom guidance. Where probiotic advice differs, this package gives the newer AGA bloating guidance priority.
Read Clinical guidance: World Gastroenterology Organisation: Common GI symptomsPHGG with antibiotic treatmentThis particular soluble fiber has one small add-on trial.One small randomized trialEvidence check
Before considering this
Partially hydrolysed guar gum is a soluble-fiber supplement. One trial added it to rifaximin. Check whether it fits your constipation or bloating before adding it to a prescribed course.
What to look for: The test was more likely to become negative in one trial. Extra symptom relief was not clearly demonstrated.
Keep in mind: The study did not establish a clear extra symptom benefit. Fiber can worsen bloating in some people.
Read the evidence 1 source
Adults; match the option to the diagnosed problem.
Clinical trial: rifaximin with partially hydrolysed guar gum for small intestinal bacterial overgrowthRandomized trial · 77 patients
- Who took part
- Breath-test-positive patients with SIBO risk factors
- How long
- 10 days; repeat assessment 1 month after treatment
Compared with: Rifaximin plus PHGG versus rifaximin alone.
What the source found: Tests cleared in 85.0% of people on rifaximin plus partially hydrolyzed guar gum versus 62.1% on rifaximin alone, including dropouts.
Digestive symptoms: No clear extra improvement among those whose tests normalized.
Breath test or culture: 85.0% versus 62.1% clearance.
Recurrence: Not established.
Thinking and memory: No objective cognitive treatment outcome.
Important limit: One small trial. Symptom comparisons among successfully treated patients did not show a clear difference. This does not justify adding every prebiotic.
Read Furnari et al. (2010): Clinical trial: rifaximin with partially hydrolysed guar gum for small intestinal bacterial overgrowthTreat slow digestion when it is presentSome people need treatment for a movement problem as well as overgrowth.Guideline-supported assessmentUnderlying condition
What this involves
Describe early fullness, nausea, vomiting or severe constipation. The relevant next check may assess stomach emptying or bowel transit. Treatment depends on what it finds.
What to look for: Better eating, emptying or bowel comfort.
Keep in mind: Prokinetic means a medicine that helps gut movement. Evidence for taking one solely to prevent SIBO relapse is limited.
Read about delayed stomach emptying
Read the evidence 2 sources
Adults; match the option to the diagnosed problem.
AGA Clinical Practice Update on Small Intestinal Bacterial Overgrowth: Expert ReviewExpert guidance · Expert review, not a patient trial
- Who took part
- People evaluated or treated for SIBO
- How long
- Published 2020
Compared with: Not a treatment comparison.
What the source found: Treatment means dealing with an underlying cause, correcting nutritional deficiencies and, where appropriate, taking antibiotics. Severe malabsorption needs extra attention.
Digestive symptoms: Symptom and nutritional response guide care; no pooled treatment estimate.
Breath test or culture: Not assessed as a treatment outcome.
Recurrence: Not established.
Thinking and memory: No objective cognitive treatment outcome.
Important limit: The best antibiotic approach and SIBO's role in common functional bowel symptoms are still unclear.
Read Quigley et al. (2020): AGA Clinical Practice Update on Small Intestinal Bacterial Overgrowth: Expert ReviewLow-Dose Nocturnal Tegaserod or Erythromycin Delays Symptom Recurrence After Treatment of IBS Based on Presumed Bacterial OvergrowthRetrospective chart review · 64 patients in a retrospective chart review
- Who took part
- irritable bowel syndrome (IBS) patients treated for presumed bacterial overgrowth
- How long
- Time to recurrence after prior response
Compared with: Nonrandomized maintenance-treatment groups.
What the source found: Reported longer symptom-free intervals with some motility medicines.
Digestive symptoms: Not assessed as a treatment outcome.
Breath test or culture: Not assessed as a treatment outcome.
Recurrence: Possible delay, with substantial uncertainty.
Thinking and memory: No objective cognitive treatment outcome.
Important limit: Not randomized. The untreated comparison group included only six people. This does not establish prucalopride or another modern prokinetic as routine SIBO prevention.
Read Pimentel et al. (2009): Low-Dose Nocturnal Tegaserod or Erythromycin Delays Symptom Recurrence After Treatment of IBS Based on Presumed Bacterial OvergrowthCheck medicines that slow your gutA prescribed medicine may be adding constipation or sluggish digestion.Medication reviewUnderlying condition
What this involves
Bring a complete medicine list, including painkillers, supplements and acid-suppressing drugs. Check whether a safer alternative or constipation plan is appropriate.
What to look for: Less medicine-related constipation or sleepiness.
Keep in mind: Stay on needed treatment until an agreed change starts. An association with acid suppression does not prove it caused your SIBO.
Read the evidence 2 sources
Adults; match the option to the diagnosed problem.
ACG Clinical Guideline: Small Intestinal Bacterial OvergrowthClinical guideline · Guideline, not a patient trial
- Who took part
- Adults with suspected or symptomatic SIBO; methane testing considered with constipation
- How long
- Published 2020
Compared with: Not a treatment comparison.
What the source found: Supports selected breath testing and antibiotics for symptomatic SIBO; recommendations have low or very low certainty. Methane-producing organisms are archaea and can occur beyond the small bowel.
Digestive symptoms: Not assessed as a treatment outcome.
Breath test or culture: Not assessed as a treatment outcome.
Recurrence: Not established.
Thinking and memory: No objective cognitive treatment outcome.
Important limit: Nonspecific symptoms and an imperfect test limit diagnostic certainty. This guideline does not establish one regimen for everyone.
Read Pimentel et al. (2020): ACG Clinical Guideline: Small Intestinal Bacterial OvergrowthAGA Clinical Practice Update on Small Intestinal Bacterial Overgrowth: Expert ReviewExpert guidance · Expert review, not a patient trial
- Who took part
- People evaluated or treated for SIBO
- How long
- Published 2020
Compared with: Not a treatment comparison.
What the source found: Treatment means dealing with an underlying cause, correcting nutritional deficiencies and, where appropriate, taking antibiotics. Severe malabsorption needs extra attention.
Digestive symptoms: Symptom and nutritional response guide care; no pooled treatment estimate.
Breath test or culture: Not assessed as a treatment outcome.
Recurrence: Not established.
Thinking and memory: No objective cognitive treatment outcome.
Important limit: The best antibiotic approach and SIBO's role in common functional bowel symptoms are still unclear.
Read Quigley et al. (2020): AGA Clinical Practice Update on Small Intestinal Bacterial Overgrowth: Expert ReviewCheck celiac disease when symptoms persistDiarrhea, weight loss or iron deficiency may need a different explanation.Targeted assessmentUnderlying condition
What this involves
Review whether celiac testing was done while you were still eating gluten. Repeated antibiotics will not treat celiac disease.
What to look for: A diagnosis that explains persistent symptoms and guides treatment.
Keep in mind: Starting a gluten-free diet before testing can make celiac disease harder to detect.
Read the evidence 3 sources
Adults; match the option to the diagnosed problem.
AGA Clinical Practice Update on Small Intestinal Bacterial Overgrowth: Expert ReviewExpert guidance · Expert review, not a patient trial
- Who took part
- People evaluated or treated for SIBO
- How long
- Published 2020
Compared with: Not a treatment comparison.
What the source found: Treatment means dealing with an underlying cause, correcting nutritional deficiencies and, where appropriate, taking antibiotics. Severe malabsorption needs extra attention.
Digestive symptoms: Symptom and nutritional response guide care; no pooled treatment estimate.
Breath test or culture: Not assessed as a treatment outcome.
Recurrence: Not established.
Thinking and memory: No objective cognitive treatment outcome.
Important limit: The best antibiotic approach and SIBO's role in common functional bowel symptoms are still unclear.
Read Quigley et al. (2020): AGA Clinical Practice Update on Small Intestinal Bacterial Overgrowth: Expert ReviewAGA Clinical Practice Update on Evaluation and Management of Belching, Abdominal Bloating, and DistentionClinical guidance · Expert review
- Who took part
- People with bloating, belching, constipation or visible distention
- How long
- Published 2023
Compared with: Not a treatment comparison.
What the source found: Treatment can address carbohydrate intolerance, constipation, pelvic-floor dysfunction or gut-brain symptoms. Probiotics are not recommended as a general bloating treatment.
Digestive symptoms: Supports targeted symptom management rather than one treatment for all bloating.
Breath test or culture: Not assessed as a treatment outcome.
Recurrence: Not established.
Thinking and memory: No objective cognitive treatment outcome.
Important limit: These are symptom-specific approaches. They do not establish eradication of SIBO.
Read Moshiree et al. (2023): AGA Clinical Practice Update on Evaluation and Management of Belching, Abdominal Bloating, and DistentionDiagnosis of Celiac DiseaseNIDDK patient guidance · Clinical guidance, not a patient trial
- Who took part
- People having tests for celiac disease
- How long
- Published 2020
Compared with: Not a treatment comparison.
What the source found: Blood tests and small-bowel biopsies are usual diagnostic tools. Starting a gluten-free diet before testing can change the results.
Digestive symptoms: Guides diagnosis and condition-specific care.
Breath test or culture: Does not estimate SIBO clearance.
Recurrence: Does not estimate SIBO recurrence.
Thinking and memory: No cognitive treatment outcome.
Important limit: Symptoms alone are insufficient. Someone already avoiding gluten needs an individual testing plan.
Read NIDDK patient guidance (2020): Diagnosis of Celiac DiseaseCorrect a confirmed nutrient deficiencyPoor absorption or a very restricted diet can leave you short of nutrients.Targeted nutritional careUnderlying condition
What this involves
Bring unexplained weight loss, a limited diet or previous low nutrient results to the assessment. Replace a confirmed deficiency using a plan that also addresses why it happened.
What to look for: Improvement in deficiency-related symptoms and follow-up results.
Keep in mind: Iron and other supplements can worsen gut symptoms. A blanket high-dose stack is not a SIBO treatment.
Read which nutrient checks may matter
Read the evidence 1 source
Adults; match the option to the diagnosed problem.
AGA Clinical Practice Update on Small Intestinal Bacterial Overgrowth: Expert ReviewExpert guidance · Expert review, not a patient trial
- Who took part
- People evaluated or treated for SIBO
- How long
- Published 2020
Compared with: Not a treatment comparison.
What the source found: Treatment means dealing with an underlying cause, correcting nutritional deficiencies and, where appropriate, taking antibiotics. Severe malabsorption needs extra attention.
Digestive symptoms: Symptom and nutritional response guide care; no pooled treatment estimate.
Breath test or culture: Not assessed as a treatment outcome.
Recurrence: Not established.
Thinking and memory: No objective cognitive treatment outcome.
Important limit: The best antibiotic approach and SIBO's role in common functional bowel symptoms are still unclear.
Read Quigley et al. (2020): AGA Clinical Practice Update on Small Intestinal Bacterial Overgrowth: Expert ReviewWhen digestion improves but thinking does notPersistent brain fog deserves its own assessment.Direct evidence is limitedAssessment
What this involves
Compare what improved in your digestion with what still affects memory, alertness or concentration. Bring sleepiness, medication changes or difficulty eating to that review.
What to look for: A plan aimed at the remaining thinking problem.
Keep in mind: Sudden confusion, new weakness or difficulty speaking needs urgent assessment, even if you have SIBO.
Read about brain fog after treatment
Read the evidence 3 sources
Adults; match the option to the diagnosed problem.
Brain fogginess, gas and bloating: a link between SIBO, probiotics and metabolic acidosisSelected observational study · 30 with brain fog and 8 without
- Who took part
- Patients with intact bowel, gas/bloating and episodic brain fog; a small comparison group
- How long
- Testing plus follow-up after treatment changes
Compared with: Selected symptomatic group versus 8 without brain fog; uncontrolled treatment follow-up.
What the source found: In a selected group with digestive symptoms and brain fog, participants stopped probiotics, some took antibiotics, and researchers reported improvement.
Digestive symptoms: Not assessed as a treatment outcome.
Breath test or culture: Not assessed as a treatment outcome.
Recurrence: Not established.
Thinking and memory: Self-reported episodes; not a blinded objective cognitive-treatment trial.
Important limit: Two changes occurred together, without randomized treatment. The study cannot establish probiotic causation or an antibiotic cure for everyday brain fog.
Read Rao et al. (2018): Brain fogginess, gas and bloating: a link between SIBO, probiotics and metabolic acidosis'Brain Fogginess' and D-Lactic Acidosis: Probiotics Are Not the CausePublished scientific response · No new trial
- Who took part
- Critique of the 2018 selected-patient report
- How long
- Published 2018
Compared with: Not a treatment comparison.
What the source found: Challenges the proposed probiotic causation and interpretation of D-lactic acidosis.
Digestive symptoms: Not assessed as a treatment outcome.
Breath test or culture: Not assessed as a treatment outcome.
Recurrence: Not established.
Thinking and memory: No new cognitive data.
Important limit: A critique is not proof that no individual reacts to a probiotic. Both sides reported relevant commercial interests.
Read Quigley et al. (2018): 'Brain Fogginess' and D-Lactic Acidosis: Probiotics Are Not the CauseBrain Fog in Gastrointestinal Disorders: Small Intestinal Bacterial Overgrowth, Gastroparesis, Irritable Bowel SyndromeObservational study · 102 patients; 55 reported brain fog
- Who took part
- Patients undergoing breath testing
- How long
- Cross-sectional assessment
Compared with: Patients with and without reported brain fog.
What the source found: Brain fog was linked to gastroparesis and IBS, but not positive SIBO or IMO tests.
Digestive symptoms: Not assessed as a treatment outcome.
Breath test or culture: Not assessed as a treatment outcome.
Recurrence: Not established.
Thinking and memory: Self-reported brain fog; no treatment effect tested.
Important limit: Associations cannot identify a cause or prove that treating either associated disorder clears brain fog.
Read El Halabi et al. (2025): Brain Fog in Gastrointestinal Disorders: Small Intestinal Bacterial Overgrowth, Gastroparesis, Irritable Bowel SyndromeInvestigate diarrhea that keeps goingBile-acid diarrhea, celiac disease and other conditions can resemble SIBO.Diagnosis-specific careAssessment
What this involves
Explain stool urgency, nighttime symptoms, weight loss, prior surgery and recent antibiotics. These details help decide which tests or treatment fit.
What to look for: Fewer urgent or watery bowel movements once the cause is treated.
Keep in mind: Blood in stool, fever, dehydration or severe pain needs prompt assessment.
Read the evidence 3 sources
Adults; match the option to the diagnosed problem.
AGA Clinical Practice Update on Small Intestinal Bacterial Overgrowth: Expert ReviewExpert guidance · Expert review, not a patient trial
- Who took part
- People evaluated or treated for SIBO
- How long
- Published 2020
Compared with: Not a treatment comparison.
What the source found: Treatment means dealing with an underlying cause, correcting nutritional deficiencies and, where appropriate, taking antibiotics. Severe malabsorption needs extra attention.
Digestive symptoms: Symptom and nutritional response guide care; no pooled treatment estimate.
Breath test or culture: Not assessed as a treatment outcome.
Recurrence: Not established.
Thinking and memory: No objective cognitive treatment outcome.
Important limit: The best antibiotic approach and SIBO's role in common functional bowel symptoms are still unclear.
Read Quigley et al. (2020): AGA Clinical Practice Update on Small Intestinal Bacterial Overgrowth: Expert ReviewWorld Gastroenterology Organisation: Common GI symptomsClinical guidance · Guideline, not a SIBO trial
- Who took part
- People with common digestive symptoms
- How long
- Guideline text inspected September 2026
Compared with: Not a treatment comparison.
What the source found: Covers symptom evaluation, alarm features and simple food/eating adjustments. Describes uncertain benefit from simethicone and activated charcoal for gas.
Digestive symptoms: Not assessed as a treatment outcome.
Breath test or culture: Not assessed as a treatment outcome.
Recurrence: Not established.
Thinking and memory: No objective cognitive treatment outcome.
Important limit: Older general symptom guidance. Where probiotic advice differs, this package gives the newer AGA bloating guidance priority.
Read Clinical guidance: World Gastroenterology Organisation: Common GI symptomsGuidelines for the investigation of chronic diarrhoea in adults: British Society of Gastroenterology, 3rd editionClinical guideline · Clinical guidance, not a patient trial
- Who took part
- Adults with chronic diarrhea
- How long
- Published 2018
Compared with: Not a treatment comparison.
What the source found: Tests can find celiac disease, inflammation, bile-acid diarrhea, microscopic colitis and malabsorption. Your symptoms and risk decide which tests you need.
Digestive symptoms: Guides diagnosis and condition-specific care.
Breath test or culture: Does not estimate SIBO clearance.
Recurrence: Does not estimate SIBO recurrence.
Thinking and memory: No cognitive treatment outcome.
Important limit: This is a differential-diagnosis guideline, not evidence that all diarrhea needs all tests.
Read Arasaradnam et al. (2018): Guidelines for the investigation of chronic diarrhoea in adults: British Society of Gastroenterology, 3rd editionTreat ongoing bowel pain and sensitivityGut-directed therapy can help some people whose symptoms continue after other treatment.Evidence for gut-brain disordersSymptom treatment
What this involves
Gut-focused cognitive behavioural therapy (CBT) or hypnotherapy can help with bowel pain, urgency and fear around symptoms. Sessions teach skills you practise between appointments. Choose a programme that addresses the bowel problem you want to improve.
What to look for: Less disruption from persistent bowel symptoms.
Keep in mind: This treats symptoms of a gut-brain disorder. No study has shown that it removes bacterial overgrowth.
Read the evidence 1 source
Adults; match the option to the diagnosed problem.
AGA Clinical Practice Update on Evaluation and Management of Belching, Abdominal Bloating, and DistentionClinical guidance · Expert review
- Who took part
- People with bloating, belching, constipation or visible distention
- How long
- Published 2023
Compared with: Not a treatment comparison.
What the source found: Treatment can address carbohydrate intolerance, constipation, pelvic-floor dysfunction or gut-brain symptoms. Probiotics are not recommended as a general bloating treatment.
Digestive symptoms: Supports targeted symptom management rather than one treatment for all bloating.
Breath test or culture: Not assessed as a treatment outcome.
Recurrence: Not established.
Thinking and memory: No objective cognitive treatment outcome.
Important limit: These are symptom-specific approaches. They do not establish eradication of SIBO.
Read Moshiree et al. (2023): AGA Clinical Practice Update on Evaluation and Management of Belching, Abdominal Bloating, and DistentionHerbal SIBO treatmentsEvidence for herbal mixtures is much weaker than the marketing often suggests.Limited nonrandomized evidenceEvidence check
Before considering this
Before buying oregano oil, berberine, allicin or a mixture, ask for research on that exact product and check interactions with a pharmacist.
What to look for: Avoiding a costly or poorly tolerated mixture without clear evidence.
Keep in mind: The often-cited comparison did not prove herbs equal antibiotics. Individual ingredients cannot inherit the results of a multi-ingredient blend.
Read the evidence 2 sources
Adults; match the option to the diagnosed problem.
Herbal Therapy Is Equivalent to Rifaximin for the Treatment of Small Intestinal Bacterial OvergrowthNonrandomized retrospective comparison · 104 with follow-up: 37 herbs, 67 rifaximin
- Who took part
- Patients choosing herbal combinations or rifaximin and completing follow-up
- How long
- 4-week treatment courses
Compared with: Patient-chosen proprietary herbal combinations versus rifaximin.
What the source found: Negative follow-up breath tests occurred in 46% versus 34%; the difference was not statistically significant.
Digestive symptoms: Not assessed as a treatment outcome.
Breath test or culture: 46% versus 34% negative follow-up tests.
Recurrence: Not established.
Thinking and memory: No objective cognitive treatment outcome.
Important limit: Despite the title, this was not an equivalence trial. Patient choice, missing follow-up and multi-ingredient mixtures prevent claims that individual herbs work as well as antibiotics.
Read Chedid et al. (2014): Herbal Therapy Is Equivalent to Rifaximin for the Treatment of Small Intestinal Bacterial OvergrowthAlternative Treatment Approaches to Small Intestinal Bacterial Overgrowth: A Systematic ReviewSystematic review · 8 included studies
- Who took part
- Small, varied SIBO treatment populations
- How long
- Protocols varied
Compared with: Not a treatment comparison.
What the source found: Probiotics, diets and herbal products have early results but lack large standardized trials.
Digestive symptoms: Not assessed as a treatment outcome.
Breath test or culture: Not assessed as a treatment outcome.
Recurrence: Not established.
Thinking and memory: No objective cognitive treatment outcome.
Important limit: Different tests, products and symptom measures make comparisons unreliable. Results do not validate a generic supplement stack.
Read Nickles et al. (2021): Alternative Treatment Approaches to Small Intestinal Bacterial Overgrowth: A Systematic ReviewMeal spacing without going hungryLong fasting gaps are not a proven way to prevent relapse.Prevention evidence is limitedPractical help
Start here
Choose meal timing that lets you eat enough and manage symptoms. Small frequent meals may suit some conditions, including delayed stomach emptying, better than long gaps.
What to look for: A schedule you can sustain without weakness or unwanted weight loss.
Keep in mind: Eat the food you need for diabetes treatment, pregnancy or malnutrition, even on a gut-cleansing schedule.
Read the evidence 3 sources
Adults; match the option to the diagnosed problem.
Your gut contracts between meals for a reason, but no specific fasting schedule is a tested SIBO cure.
AGA Clinical Practice Update on Small Intestinal Bacterial Overgrowth: Expert ReviewExpert guidance · Expert review, not a patient trial
- Who took part
- People evaluated or treated for SIBO
- How long
- Published 2020
Compared with: Not a treatment comparison.
What the source found: Treatment means dealing with an underlying cause, correcting nutritional deficiencies and, where appropriate, taking antibiotics. Severe malabsorption needs extra attention.
Digestive symptoms: Symptom and nutritional response guide care; no pooled treatment estimate.
Breath test or culture: Not assessed as a treatment outcome.
Recurrence: Not established.
Thinking and memory: No objective cognitive treatment outcome.
Important limit: The best antibiotic approach and SIBO's role in common functional bowel symptoms are still unclear.
Read Quigley et al. (2020): AGA Clinical Practice Update on Small Intestinal Bacterial Overgrowth: Expert ReviewAGA Clinical Practice Update on the Role of Diet in Irritable Bowel Syndrome: Expert ReviewClinical guidance · Expert review
- Who took part
- People with irritable bowel syndrome (IBS); not a SIBO-eradication study
- How long
- Low-FODMAP restriction no more than 4 to 6 weeks before reintroduction
Compared with: Not a treatment comparison.
What the source found: Supports a limited low-FODMAP trial followed by reintroduction and a personalized diet. Soluble fiber has evidence for IBS symptoms.
Digestive symptoms: IBS symptom management, not bacterial clearance.
Breath test or culture: SIBO clearance not demonstrated.
Recurrence: Not established.
Thinking and memory: No objective cognitive treatment outcome.
Important limit: More restriction is a poor fit for people with malnutrition risk or disordered eating. There is no established SIBO clearance effect.
Read Clinical guidance (2022): AGA Clinical Practice Update on the Role of Diet in Irritable Bowel Syndrome: Expert ReviewLow-Dose Nocturnal Tegaserod or Erythromycin Delays Symptom Recurrence After Treatment of IBS Based on Presumed Bacterial OvergrowthRetrospective chart review · 64 patients in a retrospective chart review
- Who took part
- irritable bowel syndrome (IBS) patients treated for presumed bacterial overgrowth
- How long
- Time to recurrence after prior response
Compared with: Nonrandomized maintenance-treatment groups.
What the source found: Reported longer symptom-free intervals with some motility medicines.
Digestive symptoms: Not assessed as a treatment outcome.
Breath test or culture: Not assessed as a treatment outcome.
Recurrence: Possible delay, with substantial uncertainty.
Thinking and memory: No objective cognitive treatment outcome.
Important limit: Not randomized. The untreated comparison group included only six people. This does not establish prucalopride or another modern prokinetic as routine SIBO prevention.
Read Pimentel et al. (2009): Low-Dose Nocturnal Tegaserod or Erythromycin Delays Symptom Recurrence After Treatment of IBS Based on Presumed Bacterial OvergrowthCheck the cost of the actual treatmentPrescription coverage and the need for testing vary.Access supportPractical help
Start here
Request a quote for the whole prescribed course. Ask about coverage review and licensed local alternatives before buying. Use the real diagnosis when requesting insurance approval.
What to look for: An affordable plan you understand.
Keep in mind: Forum prices and import advice may not apply where you live. A higher price does not imply a better chance of recovery.
Read the evidence 2 sources
Adults; match the option to the diagnosed problem.
Xifaxan: US prescribing informationMedicine label · Regulatory label, not a SIBO trial
- Who took part
- People prescribed rifaximin
- How long
- Inspected September 2026; displayed label revised 2023
Compared with: Not a treatment comparison.
What the source found: US listed indications are IBS with diarrhea, specified travelers’ diarrhea and prevention of recurrent overt hepatic encephalopathy. SIBO is not a listed indication. The label warns about allergy and C. difficile-associated diarrhea.
Digestive symptoms: Not assessed as a treatment outcome.
Breath test or culture: Not assessed as a treatment outcome.
Recurrence: Not established.
Thinking and memory: No objective cognitive treatment outcome.
Important limit: This label does not define SIBO dosing. Local approvals and available formulations can differ.
Read Medicine label (2023): Xifaxan: US prescribing informationRifaximin: VA formulary information and SIBO criteria-for-use linksOfficial access guidance · Administrative policy, not a trial
- Who took part
- US Veterans Health Administration patients
- How long
- Data refresh displayed June 2026
Compared with: Not a treatment comparison.
What the source found: Lists SIBO treatment and recurrence-prevention criteria documents. Rifaximin is non-formulary and requires review/approval.
Digestive symptoms: Not assessed as a treatment outcome.
Breath test or culture: Not assessed as a treatment outcome.
Recurrence: Not established.
Thinking and memory: No objective cognitive treatment outcome.
Important limit: Coverage rules outside the VA differ. Administrative criteria are not a guarantee of benefit or coverage.
Read Official access guidance (2026): Rifaximin: VA formulary information and SIBO criteria-for-use linksGet new treatment symptoms checkedNew severe diarrhea, vomiting or weakness needs attention.Medicine safety guidance
What this involves
Contact the prescribing or diet team if symptoms worsen substantially. Seek urgent help for fainting, inability to keep fluids down, severe pain, blood in stool or new confusion.
What to look for: Early recognition of an adverse effect, dehydration or another illness.
Keep in mind: Calling it die-off can't show that treatment is working. A severe reaction is no reason to step up antibiotics or herbs.
Read the evidence 3 sources
Adults; match the option to the diagnosed problem.
Xifaxan: US prescribing informationMedicine label · Regulatory label, not a SIBO trial
- Who took part
- People prescribed rifaximin
- How long
- Inspected September 2026; displayed label revised 2023
Compared with: Not a treatment comparison.
What the source found: US listed indications are IBS with diarrhea, specified travelers’ diarrhea and prevention of recurrent overt hepatic encephalopathy. SIBO is not a listed indication. The label warns about allergy and C. difficile-associated diarrhea.
Digestive symptoms: Not assessed as a treatment outcome.
Breath test or culture: Not assessed as a treatment outcome.
Recurrence: Not established.
Thinking and memory: No objective cognitive treatment outcome.
Important limit: This label does not define SIBO dosing. Local approvals and available formulations can differ.
Read Medicine label (2023): Xifaxan: US prescribing informationNeomycin sulfate: boxed warning and prescribing informationMedicine label · Regulatory label, not a SIBO trial
- Who took part
- People prescribed oral neomycin
- How long
- Displayed label revised October 2022
Compared with: Not a treatment comparison.
What the source found: Oral neomycin can cause kidney damage and permanent hearing loss. Kidney function, hearing/balance risk, other medicines and pregnancy require review; toxicity can appear after treatment.
Digestive symptoms: Not assessed as a treatment outcome.
Breath test or culture: Not assessed as a treatment outcome.
Recurrence: Not established.
Thinking and memory: No objective cognitive treatment outcome.
Important limit: Your body absorbs little neomycin, but these risks remain. You can't take it if you have inflammatory or ulcerative bowel disease or a bowel blockage.
Read Medicine label (2022): Neomycin sulfate: boxed warning and prescribing informationWorld Gastroenterology Organisation: Common GI symptomsClinical guidance · Guideline, not a SIBO trial
- Who took part
- People with common digestive symptoms
- How long
- Guideline text inspected September 2026
Compared with: Not a treatment comparison.
What the source found: Covers symptom evaluation, alarm features and simple food/eating adjustments. Describes uncertain benefit from simethicone and activated charcoal for gas.
Digestive symptoms: Not assessed as a treatment outcome.
Breath test or culture: Not assessed as a treatment outcome.
Recurrence: Not established.
Thinking and memory: No objective cognitive treatment outcome.
Important limit: Older general symptom guidance. Where probiotic advice differs, this package gives the newer AGA bloating guidance priority.
Read Clinical guidance: World Gastroenterology Organisation: Common GI symptomsStool microbiome testsA stool bacterial profile cannot tell you what is happening throughout your small bowel.Not validated for diagnosing SIBOEvidence check
Before considering this
Before paying, ask whether the result changes an established medical decision. For SIBO, the clinical history and a suitable small-bowel assessment matter more than a commercial stool score.
What to look for: Avoiding a test that leads only to another supplement list.
Keep in mind: Ordinary stool tests for infection or inflammation have different purposes and may still be useful.
Read the evidence 2 sources
Adults; match the option to the diagnosed problem.
AGA Clinical Practice Update on Small Intestinal Bacterial Overgrowth: Expert ReviewExpert guidance · Expert review, not a patient trial
- Who took part
- People evaluated or treated for SIBO
- How long
- Published 2020
Compared with: Not a treatment comparison.
What the source found: Treatment means dealing with an underlying cause, correcting nutritional deficiencies and, where appropriate, taking antibiotics. Severe malabsorption needs extra attention.
Digestive symptoms: Symptom and nutritional response guide care; no pooled treatment estimate.
Breath test or culture: Not assessed as a treatment outcome.
Recurrence: Not established.
Thinking and memory: No objective cognitive treatment outcome.
Important limit: The best antibiotic approach and SIBO's role in common functional bowel symptoms are still unclear.
Read Quigley et al. (2020): AGA Clinical Practice Update on Small Intestinal Bacterial Overgrowth: Expert ReviewCritical appraisal of the SIBO hypothesis and breath testing: ESNM/ANMS clinical practice updateSociety-endorsed critical review · Critical review, not a patient trial
- Who took part
- Especially irritable bowel syndrome (IBS) and other disorders of gut-brain interaction
- How long
- Published 2024
Compared with: Not a treatment comparison.
What the source found: It questions routinely diagnosing SIBO by breath test in people with IBS, especially when fast-moving food skews lactulose results. It recognizes classic overgrowth when gut anatomy or movement is impaired.
Digestive symptoms: Not assessed as a treatment outcome.
Breath test or culture: Not assessed as a treatment outcome.
Recurrence: Not established.
Thinking and memory: No objective cognitive treatment outcome.
Important limit: Its recommendations differ from ACG guidance. These disagreements should remain visible when a result is borderline or treatment repeatedly fails.
Read Kashyap et al. (2024): Critical appraisal of the SIBO hypothesis and breath testing: ESNM/ANMS clinical practice updateSkip an unexplained supplement stackBiofilm products, binders and cleanses add cost without a clear treatment plan.No established SIBO benefitEvidence check
Before considering this
Ask what each product should improve and which human SIBO trial supports it. Leave out extras that have no clear purpose in your care.
What to look for: Fewer unnecessary products and less avoidable expense.
Keep in mind: Worsening pain, diarrhea or weakness needs assessment. Adding more detox products can delay that assessment.
Read the evidence 3 sources
Adults; match the option to the diagnosed problem.
Critical appraisal of the SIBO hypothesis and breath testing: ESNM/ANMS clinical practice updateSociety-endorsed critical review · Critical review, not a patient trial
- Who took part
- Especially irritable bowel syndrome (IBS) and other disorders of gut-brain interaction
- How long
- Published 2024
Compared with: Not a treatment comparison.
What the source found: It questions routinely diagnosing SIBO by breath test in people with IBS, especially when fast-moving food skews lactulose results. It recognizes classic overgrowth when gut anatomy or movement is impaired.
Digestive symptoms: Not assessed as a treatment outcome.
Breath test or culture: Not assessed as a treatment outcome.
Recurrence: Not established.
Thinking and memory: No objective cognitive treatment outcome.
Important limit: Its recommendations differ from ACG guidance. These disagreements should remain visible when a result is borderline or treatment repeatedly fails.
Read Kashyap et al. (2024): Critical appraisal of the SIBO hypothesis and breath testing: ESNM/ANMS clinical practice updateAlternative Treatment Approaches to Small Intestinal Bacterial Overgrowth: A Systematic ReviewSystematic review · 8 included studies
- Who took part
- Small, varied SIBO treatment populations
- How long
- Protocols varied
Compared with: Not a treatment comparison.
What the source found: Probiotics, diets and herbal products have early results but lack large standardized trials.
Digestive symptoms: Not assessed as a treatment outcome.
Breath test or culture: Not assessed as a treatment outcome.
Recurrence: Not established.
Thinking and memory: No objective cognitive treatment outcome.
Important limit: Different tests, products and symptom measures make comparisons unreliable. Results do not validate a generic supplement stack.
Read Nickles et al. (2021): Alternative Treatment Approaches to Small Intestinal Bacterial Overgrowth: A Systematic ReviewWorld Gastroenterology Organisation: Common GI symptomsClinical guidance · Guideline, not a SIBO trial
- Who took part
- People with common digestive symptoms
- How long
- Guideline text inspected September 2026
Compared with: Not a treatment comparison.
What the source found: Covers symptom evaluation, alarm features and simple food/eating adjustments. Describes uncertain benefit from simethicone and activated charcoal for gas.
Digestive symptoms: Not assessed as a treatment outcome.
Breath test or culture: Not assessed as a treatment outcome.
Recurrence: Not established.
Thinking and memory: No objective cognitive treatment outcome.
Important limit: Older general symptom guidance. Where probiotic advice differs, this package gives the newer AGA bloating guidance priority.
Read Clinical guidance: World Gastroenterology Organisation: Common GI symptomsNo matching options. Try a shorter search or choose “All difficulties”.
SIBO treatment questionsRelapse, food, testing and treatment problems
Why did symptoms return after antibiotics?
The original problem may still be present, including slow movement or altered bowel anatomy. Symptoms can also return for reasons other than overgrowth. Review what improved and for how long.
Work out why symptoms returned · Treat slow digestion when it is present
Rifaximin did nothing. What next?
Check whether the test and diagnosis fit the problem before another course.
Is rifaximin worth the money?
It helps some people, but a high price cannot guarantee recovery. Confirm why it was chosen, the full cost and the plan if it fails. Coverage review may help.
Rifaximin for confirmed overgrowth · Check the cost of the actual treatment
Do herbs work as well as antibiotics?
The well-known comparison was small and patients chose their treatment. It could not establish equal benefit. There is no strong evidence for a universal herbal combination.
Are severe symptoms during treatment just die-off?
Severe diarrhea, vomiting, dehydration or confusion needs assessment. The term die-off cannot distinguish a treatment effect from an adverse reaction or another illness.
Should I keep going if an elemental diet makes me very weak?
Contact the team supervising it promptly. They need to check intake, fluid losses and whether the formula is suitable. Fainting, inability to keep fluids down or new confusion needs urgent help.
Understand an elemental diet · Get new treatment symptoms checked
Can SIBO treatment clear brain fog?
Small studies describe improvement in selected patients. They do not establish a reliable brain-fog treatment. If digestive symptoms improve but thinking does not, investigate the remaining problem separately.
When digestion improves but thinking does not · Correct a confirmed nutrient deficiency
Do I need a negative test if I feel much better?
A test result is useful when it changes a decision. Routine test-of-cure benefits are not established for everyone. Ask why your doctor suggests retesting and what follows each result.
Is neomycin safe just because it stays mostly in the gut?
Some gets absorbed. Kidney damage and permanent hearing loss are important risks, so a prescriber needs to check suitability and monitoring.
Do I need to stay low-FODMAP forever?
The strict phase is meant to be short. Reintroduction finds the broadest diet you can tolerate. More restriction is not proof of better SIBO control.
Do I need a prokinetic after antibiotics?
A prokinetic helps gut movement. It may fit a diagnosed movement problem, but evidence for prescribing one to everybody to prevent SIBO relapse is limited.
Treat slow digestion when it is present · Meal spacing without going hungry
What does methane change?
Methane is linked to constipation and can affect treatment choices. The term IMO includes methane-producing organisms outside the small bowel. A gas result alone cannot choose the safest treatment.
Does rotten-egg gas prove hydrogen sulfide overgrowth?
No. Smell alone cannot diagnose a gas subtype. Newer breath-gas research is useful, but diagnostic cutoffs and treatment benefits still need stronger validation.
Why did a probiotic make me feel worse?
The timing is worth reviewing, but it cannot identify the cause on its own. Adding more probiotics or herbs can make it harder to tell what changed.
Can a stool microbiome test diagnose SIBO?
A stool sample does not directly measure bacteria in the small bowel. Infection and inflammation stool tests can answer other questions, but a commercial microbiome score cannot confirm SIBO.
Does fiber feed the problem?
Fibers differ. Some help constipation or IBS symptoms, while others make gas worse. One small trial suggests PHGG may help alongside antibiotics. That doesn't apply to all prebiotics.
Find a fiber you can tolerate · PHGG with antibiotic treatment
Should I fast between meals to stop relapse?
No study has shown that a specific fasting schedule reliably prevents relapse. Enough nutrition and management of the actual movement problem matter more than forcing long gaps.
Meal spacing without going hungry · Treat slow digestion when it is present
Could it be celiac disease or another bowel condition?
Yes. Lasting diarrhea, weight loss, deficiencies, constipation or nausea may have another cause, especially if treatment didn't help.
Check celiac disease when symptoms persist · Investigate diarrhea that keeps going
Do I need biofilm disruptors, charcoal or a detox?
This review did not establish a SIBO benefit that justifies a routine stack of these products. Ask for evidence on the exact product. Feeling worse is no reason to add more.
Skip an unexplained supplement stack · Get new treatment symptoms checked
Managing
I treated SIBO but still have brain fog
Bloating, bowel symptoms or a breath-test result can improve while memory, concentration or processing remains unchanged. Those are separate outcomes.
A SIBO diagnosis can be correct without being the reason your thinking stayed poor. The digestive condition and the remaining cognitive problem may need separate explanations.
After the plan
What changed after treatment?
Digestive and cognitive symptoms both improved
This strengthens the connection, especially when the same meal-linked episode stopped. It still does not prove which gas or metabolite caused the cognitive change.
Digestive symptoms improved, cognition did not
SIBO looks less likely to explain the remaining thinking problem. Ask about sleep, medicines, nutrient deficiencies, glucose, migraine, autonomic symptoms and neurological causes.
Nothing improved
Recheck the diagnosis, test preparation, treatment target, constipation, slow emptying and other gut conditions before repeating the same plan.
Improvement was followed by relapse
Ask what allowed overgrowth to return. Anatomy, delayed movement, constipation, diabetes, thyroid disease and medicines may matter more than another short course alone.
Does recurrence mean treatment failed?
Not necessarily. One older treated cohort reported recurrence in about 44% by nine months. That figure describes a specific group and does not predict one person's future. [8]
If symptoms and a positive test return, ask whether constipation, delayed movement, altered anatomy, diabetes, thyroid disease or a medicine is still slowing the gut. Another short course may not correct the reason the overgrowth returned.
Why it may return
What should be checked when SIBO keeps returning?
Stomach emptying: early fullness, nausea, vomiting and food that seems to remain for hours.
Small-bowel and colon movement: severe constipation, diabetes, thyroid disease, scleroderma, neurological disease and opioid use.
Anatomy: previous surgery, adhesions, blind loops, diverticula, strictures or radiation injury.
Nutrition and absorption: weight loss, anemia, low B12, low folate, low albumin or difficulty maintaining a broad diet.
Does clearing a breath test mean brain fog should clear?
No. A normal breath test, less bloating and clearer thinking are three separate outcomes.
Antimicrobial research
Most research reports changes in gas values or digestive symptoms. Reliable cognitive recovery rates are not available, so those results cannot tell an individual reader whether their thinking will improve.
Elemental-diet research
Diet
Should I stay on a low-FODMAP diet?
A short, structured low-FODMAP phase can reduce fermentable-food symptoms in some people with IBS. It is not proof of SIBO and is not designed as a permanent diet. Reintroduction matters because long restriction can narrow food variety, increase fear around eating and make poor nutrition harder to see.
After months of restriction, also check whether you are eating enough energy, protein, fibre and micronutrients. A useful plan should leave room for a varied diet and a life that is not organised around food rules.
Probiotic question
Should people with SIBO avoid probiotics?
The 2018 investigators selected the brain-fog group, and every member used probiotics. They stopped probiotics while also receiving antimicrobials, so the study cannot show that probiotics caused every case or that all people with SIBO should avoid them. [1]
If a probiotic clearly came before a new meal-linked cognitive episode, report the product, strains, start date and symptom change.
Indirect cognitive causes
Which nutrient checks may matter?
Your doctor picks blood tests based on your history. No SIBO panel suits everyone. CBC, ferritin, B12, folate, albumin and selected chemistry tests become more relevant with weight loss, diarrhea, surgery, anemia, numbness, restricted eating or signs of poor absorption.
A nutrient deficiency can explain cognitive symptoms even when the overgrowth itself does not. Treating the digestive condition and correcting the deficiency are related but separate jobs.
Interactive timing record
How long after a meal do symptoms start?
This records the time between a meal and the start of symptoms. It does not tell you when to eat. Use naturally occurring episodes only.
Meal and symptom timing
Enter when your meal ended and when your usual digestive or thinking problem began. The delay can help reconstruct an episode. This timing record can't diagnose SIBO or prove gut fermentation caused the thinking change.
Or enter times from an earlier episode
This week
What can I do before the next review?
Tell your doctor how bloating, pain, stool frequency, food tolerance, energy and thinking each changed.
After a repeat test, get both complete reports.
List every medicine, supplement and diet change, with dates, benefits, harms and why it was stopped.
Mention early fullness, nausea, vomiting, severe constipation and past surgery. They can change the relapse plan.
If your memory, focus or thinking speed didn't change, keep looking for causes beyond your gut.
I'm supporting someone with SIBO
What another person may notice
A distinct episode after eating
They may lose the thread of a conversation, answer slowly, repeat a question, become unusually unsteady or say they feel “food drunk.” The change has a clear beginning and is different from their usual state.
Cognitive trouble that lasts between meals
They may struggle all day, including between meals. That broader problem makes sleep, medicines, nutrition, gastroparesis, pain and other causes more important.
During an episode
How can I help when thinking suddenly worsens?
Pause driving, cooking, financial decisions and other tasks where impaired judgment could cause harm.
Ask one question at a time. Write down what happened so they don't have to remember every detail later.
Record when they ate, when symptoms started, digestive changes, medicines and whether this was their usual episode.
An episode might not be SIBO. Shakiness, flushing, wheeze, faintness, one-sided weakness or speech change requires a different response.
How do I help without turning food into a fight?
Ask what the current plan allows and whether a dietitian is involved. Let them decide whether to eat a suspected trigger. Cutting more and more foods isn't proof they're solving the problem, so hold your praise.
Weight loss, fear of eating, dehydration, weakness and a shrinking list of tolerated foods deserve practical help. Offer a meal that fits their plan. Help them see a dietitian, and watch what cutting foods costs them.
The complete breath-test curves, substrate, sample times, gas values and laboratory interpretation.
The preparation sheet and an honest list of antibiotics, probiotics, laxatives, smoking, vaping, exercise and food before testing.
A dated list of medicines, supplements and diets, with what changed in digestion and what changed in thinking.
Surgery records, diabetes and thyroid history, constipation severity, weight change and any delayed-emptying symptoms.
Compare what changed
What if the digestive symptoms and cognitive problems do not change together?
The gut improves but cognition does not
Help them review sleep, medicines, nutrient deficiencies, glucose, migraine, autonomic symptoms and neurological causes. Accept that the SIBO diagnosis may not explain everything.
Early fullness and vomiting dominate
Delayed stomach emptying or obstruction may matter more than fermentation. Record how little food fills them and how long that lasts.
Symptoms occur without meals or digestive change
All-day impairment without a gut connection makes SIBO a weaker cognitive explanation.
The cognitive change is sudden or focal
New weakness, numbness, speech trouble, vision change, seizure, collapse or severe confusion is not routine SIBO brain fog.
Useful sentence
I've written down what happened to digestion and to thinking separately. I also noticed early fullness, constipation, weight change or something else that may explain why the problem keeps returning.
A brief episode after eating is different from difficulty thinking all day
Slow stomach or intestinal movement can make overgrowth more likely
Gas type is not a brain-fog subtype
Local access
How does SIBO assessment differ in the US, UK and Australia?
Test availability, the drink used, laboratory methods and payment differ. Wherever you live, ask your doctor: Why this test? How should I prepare? What does the full gas curve show? Could slow movement or altered anatomy let overgrowth return?
United States
Primary care can check warning signs and common causes. A gastroenterologist can decide whether you need a breath test, a camera test, a scan, or a test of how food moves through the gut.
- SIBO diagnosis requires digestive symptoms plus evidence of excess small-bowel bacteria or their gas production.
- Hydrogen and methane breath testing is the common noninvasive approach, but results have limitations.
- Management should address nutritional deficiencies and the condition that allowed overgrowth to occur.
United Kingdom
A GP can assess alarm symptoms and refer to gastroenterology or an NHS GI physiology service for breath testing when appropriate.
- NHS breath-test services use detailed preparation, fasting, timed samples, and hydrogen or methane measurement.
- Preparation differs by service, so the exact hospital instructions take priority.
- Guts UK notes that breath testing is indirect and can be inaccurate in some people with IBS.
Australia
Have a GP review warning symptoms, medicines, surgery, nutrition and common digestive conditions before you order a test yourself.
- Persistent bloating, weight loss, blood in stool, vomiting or signs of poor absorption need a doctor, not self-diagnosis.
- A GP can assess common digestive causes and refer to gastroenterology or a breath-test service.
- Test availability, substrate, gas measurement, preparation, and Medicare coverage vary by service.
History
How did the SIBO and brain-fog story change?
Overgrowth was first recognised after altered bowel anatomy
The early problem was often called blind-loop syndrome. Bacteria accumulated where surgery or abnormal anatomy allowed intestinal contents to stagnate. Modern SIBO discussions widened far beyond that group, but anatomy and movement still matter.
North American breath-test criteria were standardised
The consensus set commonly used hydrogen and methane thresholds. It also made preparation, sample timing and interpretation a required part of the result.
A small, selected brain fog study changed public views
The study raised a serious question about probiotics, SIBO, metabolic acidosis (acidic blood) and repeatable episodes of thinking trouble. Websites later stretched that narrow finding to explain chronic brain fog generally.
The ACG published a formal SIBO guideline
The guideline clearly recognised SIBO as a medical condition. It also stressed nonspecific symptoms, imperfect testing and the need to deal with the condition that let overgrowth develop.
A broader gastrointestinal study complicated the brain-fog claim
In 102 people having breath tests, researchers linked brain fog to gastroparesis and IBS, not to positive SIBO or methane tests. The focus moved from gas type to slow stomach emptying and the kind of thinking problem people reported.
Safety
When should I get urgent medical help?
Get urgent medical help for severe or worsening belly pain, a swollen belly, repeated vomiting, not passing stool or gas, major bleeding, black stool, fainting, severe dehydration or not keeping food and fluids down.
New confusion, trouble walking, slurred speech, one-sided weakness, numbness, vision change, seizure or collapse needs urgent checks before anyone blames SIBO. Use urgent or emergency care.
Common questions
Can SIBO cause brain fog?
It may contribute to a distinct cognitive episode in some people, especially when the same digestive and thinking symptoms occur together after eating. The direct evidence is small and selected. A positive breath test does not prove that SIBO caused persistent brain fog.
Does brain fog 30 to 90 minutes after eating prove SIBO?
No. Timing can help narrow down the cause. But glucose changes, food reactions, migraine, blood-pressure changes, slow stomach emptying and ordinary after-meal sleepiness can happen in that same period.
Can symptoms tell me whether I have hydrogen, methane or hydrogen sulfide overgrowth?
No. Symptoms can guide questions, but gas classification comes from a properly prepared and interpreted test. Gas type still does not identify the cause of the cognitive problem.
Why do I still have brain fog after SIBO treatment?
Gut symptoms and thinking can change separately. If bloating and bowel habits improve but memory, concentration or word finding don't, look again at sleep, medicines, nutrient deficiencies, glucose changes, migraine and other possible causes.
Could gastroparesis or slow gut movement explain more than SIBO?
Yes. Delayed emptying and slow intestinal movement can encourage overgrowth. A later study linked brain fog more strongly with gastroparesis and IBS than with a positive SIBO or methane breath-test result. That link doesn't prove one causes the other.
Doctor handout
Connected causes
GutCandida / Fungal OvergrowthHistamineNutrient DeficiencyThyroidMedication Side EffectsPOTSEvidence boundary
Sources
References
- Rao SSC et al. Brain fogginess, gas and bloating: a link between SIBO, probiotics and metabolic acidosis. Clinical and Translational Gastroenterology. 2018. PMID 29915215.
- El Halabi M et al. Brain fog in gastrointestinal disorders: small intestinal bacterial overgrowth, gastroparesis and irritable bowel syndrome. Journal of Clinical Gastroenterology. 2025. PMID 39495803.
- Quigley EMM et al. 'Brain Fogginess' and D-Lactic Acidosis: Probiotics Are Not the Cause. Clinical and Translational Gastroenterology. 2018. PMID 30250026.
- Pimentel M et al. ACG Clinical Guideline: Small Intestinal Bacterial Overgrowth. American Journal of Gastroenterology. 2020. PMID 32023228.
- Rezaie A et al. Hydrogen and methane-based breath testing in gastrointestinal disorders: the North American Consensus. American Journal of Gastroenterology. 2017. PMID 28323273.
- Kashyap P et al. Critical appraisal of the SIBO hypothesis and breath testing: a clinical practice update endorsed by ESNM and ANMS. Neurogastroenterology and Motility. 2024. PMID 38798120.
- Beas R et al. Prevalence of small intestinal bacterial overgrowth in patients with gastroparesis: a systematic review and meta-analysis. 2023. PMID 37070116.
- Lauritano EC et al. Small intestinal bacterial overgrowth recurrence after antibiotic therapy. American Journal of Gastroenterology. 2008. PMID 18802998.
- Pimentel M et al. A 14-day elemental diet is highly effective in normalizing the lactulose breath test. Digestive Diseases and Sciences. 2004. PMID 14992438.
- Rezaie A et al. Effect, tolerability, and safety of exclusive palatable elemental diet in patients with intestinal microbial overgrowth. Clinical Gastroenterology and Hepatology. 2025. PMID 40189034.